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Tuberculosis (TB) remains a leading cause of death from infectious diseases worldwide. 
Mycobacterium bovis is the causative agent of bovine tuberculosis (bTB) and zoonotic TB 
infection. CD4 T cells are necessary for host defense against M. bovis; however, CD4 T cell-
mediated immunity is not sufficient to prevent or eliminate the infection and additional 
components of the immune system are required for optimum host protection. The innate immune 
system has long been considered primitive and nonspecific, thought to lack the capacity to mount 
immunological memory. However, evidence suggests that the innate immune system can improve 
with pathogen exposure and adopt memory-like traits, potentially conferring resistance to TB, as 
well as other unrelated diseases. The focus of this thesis was to characterize two types of 
nonconventional memory responses in calves responding to M. bovis vaccination or virulent 
infection. 
Gamma Delta (GD) T cells are unconventional T cells that play a major role in defense 
against pathogens, especially at mucosal sites such as the lower respiratory tract. GD T cells 
participate in the response to M. bovis vaccination and infection. In the second chapter, we 
demonstrate that in cattle, virulent M. bovis infection elicits memory-like responses in circulating 
mycobacteria-specific GD T cells, characteristic of central memory (TCM) cells which have been 
reported in humans. We further show that bovine M. bovis-specific circulating GD T cells 
upregulate the surface expression of lung-homing receptors CXCR3 and CCR5, suggesting that 
GD have the capacity to home to sites of infection and participate in control of TB infection. In 
the third chapter, we expand upon our previous studies through a comparative assessment of the 
phenotype and function of M. bovis-specific GD T cells in the systemic and mucosal compartment 
following M. bovis Bacille Calmette Guerin (BCG) vaccination. We show that aerosol BCG 
immunization induces both systemic and mucosal M. bovis-specific γδ T cells with a surface 
phenotype associated with highly differentiated TCM and effector memory (TEM) cells, 
respectively. 
Evidence from epidemiological studies in humans suggests that previous exposure to M. 
bovis BCG, a live attenuated vaccine, reduces the risk of childhood mortality due to prevention of 
sepsis, diarrhea and respiratory infections. It has been suggested that the nonspecific disease 
resistance induced by BCG is mediated by an enhanced memory-like response of the innate 
immune system known as ‘trained’ immunity. In the fourth chapter, we demonstrate that in vitro 
and in vivo infection with M. bovis BCG elicits long-term memory-like traits in bovine circulating 
innate cells, but not lung resident populations, during secondary in vitro Toll-like receptor (TLR) 
challenge. Consistent with reports in other species, this cellular hyperresponsiveness correlated 
with a metabolic shift towards glycolysis. 
Together, our research suggests that effective control of M. bovis infection requires not 
only properly activated adaptive immune responses but may also benefit from nonconventional 
memory-like responses from populations such as ‘trained’ innate monocytes and differentiated GD 
T cells. Our results have important implications towards the development of novel intervention 
strategies for use against TB and related respiratory infections in humans and animals alike.  
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demonstrate that in cattle, virulent M. bovis infection elicits memory-like responses in circulating 
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upregulate the surface expression of lung-homing receptors CXCR3 and CCR5, suggesting that 
GD have the capacity for homing to sites of infection and participating in control of TB infection. 
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phenotype and functions of M. bovis-specific GD T cells in the systemic and mucosal compartment 
following M. bovis Bacille Calmette Guerin (BCG) vaccination. We show that aerosol BCG 
immunization induces both systemic and mucosal γδ T cells with a surface phenotype associated 
with highly differentiated TCM and effector memory (TEM) cells, respectively.  
Evidence from epidemiological studies in humans suggests that previous exposure to M. 
bovis BCG, a live attenuated vaccine, reduces the risk of childhood mortality due to prevention of 
sepsis, diarrhea and respiratory infections. It has been suggested that the nonspecific disease 
resistance induced by BCG is mediated by an enhanced memory-like response of the innate 
immune system known as ‘trained’ immunity. In the fourth chapter, we demonstrate that in vitro 
and in vivo infection with M. bovis BCG elicits long-term memory-like traits in bovine circulating 
innate cells, but not lung resident populations, during secondary in vitro Toll-like receptor (TLR) 
challenge. Consistent with reports in other species, this cellular hyperresponsiveness correlated 
with a metabolic shift towards glycolysis.  
Together, our research suggests that effective control of M. bovis infection requires not only 
properly activated adaptive immune responses but may also benefit from nonconventional 
memory-like responses from populations such as ‘trained’ innate monocytes and differentiated GD 
T cells. Our results have important implications towards the development of novel intervention 
strategies for use against TB and related respiratory infections in humans and animals alike.  
vi 
Table of Contents 
List of Figures .............................................................................................................................. viii 
List of Tables .................................................................................................................................. x 
Acknowledgements ........................................................................................................................ xi 
LIST OF ARTICLES ................................................................................................................... xiii 
Chapter 1 - GENERAL INTRODUCTION AND BACKGROUND ............................................. 1 
DISSERTATION ORGANIZATION .................................................................................... 1 
LITERATURE REVIEW ........................................................................................................... 2 
Immune response to M. bovis ................................................................................................. 3 
γδ T cells ................................................................................................................................. 8 
Memory-like responses of γδ T cells to Mycobacterial infection ..................................... 11 
Innate immune memory ........................................................................................................ 13 
Concluding remarks .............................................................................................................. 15 
Chapter 2 - Characterization of γδ T cell effector/memory subsets based on CD27 and CD45R 
expression in response to Mycobacterium bovis infection ...................................................... 1 
ABSTRACT ............................................................................................................................ 1 
INTRODUCTION .................................................................................................................. 3 
MATERIALS AND METHODS ............................................................................................ 5 
RESULTS ............................................................................................................................... 9 
DISCUSSION ....................................................................................................................... 21 
REFERENCES ..................................................................................................................... 25 
Chapter 3 - Characterization of mucosal and circulating bovine gd T cell responses to respiratory 
BCG vaccination ...................................................................................................................... 1 
ABSTRACT ............................................................................................................................ 1 
INTRODUCTION .................................................................................................................. 3 
MATERIALS AND METHODS ............................................................................................ 6 
RESULTS ............................................................................................................................. 14 
DISCUSSION ....................................................................................................................... 29 
REFRENCES ........................................................................................................................ 34 
vii 
Chapter 4 - Aerosol vaccination with Bacille Calmette-Guerin induces a trained innate immune 
phenotype in calves .................................................................................................................. 1 
ABSTRACT ........................................................................................................................ 1 
INTRODUCTION .............................................................................................................. 3 
MATERIALS AND METHODS ........................................................................................ 6 
RESULTS ......................................................................................................................... 13 
DISCUSSION ................................................................................................................... 23 
ACKNOWLEDGEMENTS .............................................................................................. 28 
Chapter 5 - SUMMARY AND FUTURE DIRECTIONS .............................................................. 1 
References ........................................................................................................................... 6 
Supplemental information Chapter 3 .............................................................................................. 1 
Supplemental information Chapter 4 .............................................................................................. 7 
  
viii 
List of Figures 
 
Figure 1. Determinants of protection against Mycobacteria ......................................................... 17 
Figure 2 Proliferative responses in response to in vitro stimulation with mycobacterial antigens.
 ............................................................................................................................................... 14 
Figure 3. Evaluation of CD45RO and CD45R expression on M. bovis-specific γδ and CD4 T 
cells. ...................................................................................................................................... 15 
Figure 4. CD27 expression on bovine γδ and CD4 T cells ex vivo and in response to mitogen. . 16 
Figure 5. CD27+ expression correlates with robust antigen-specific responses to M. bovis. ...... 17 
Figure 6. Phenotype of TCM, TEM and effector γδ and CD4 T cells proliferating in response to 
M. bovis. ................................................................................................................................ 18 
Figure 7. Memory marker expression of CD27 and CD62L T cell subsets of M. bovis-infected 
cattle. ..................................................................................................................................... 19 
Figure 8. Surface expression of chemokine receptors on M. bovis-specific peripheral γδ and CD4 
T cells. ................................................................................................................................... 20 
Figure 9. Cellular immune responses in the airways and peripheral blood of BCG-vaccinated 
calves. .................................................................................................................................... 20 
Figure 10. Cellular immune responses in lung-draining lymph nodes of BCG-vaccinated calves.
 ............................................................................................................................................... 21 
Figure 11. Long-term cultured and ex vivo IFNγ responses by cattle after M. bovis aerosol 
vaccination. ........................................................................................................................... 22 
Figure 12. Systemic M. bovis-specific responses in response to in vitro restimulation with 
mycobacterial antigens. ......................................................................................................... 23 
Figure 13. Circulating and Mucosal M. bovis-specific IFNγ expression in response to in vitro 
restimulation with mycobacterial antigens. .......................................................................... 24 
Figure 14. Phenotype of circulating antigen-specific γδ T cells. .................................................. 25 
Figure 15. Phenotype of mucosal antigen-specific γδ T cells. ...................................................... 26 
Figure 16. In vitro BCG infection of bovine monocytes enhances the expression of 
proinflammatory cytokines after stimulation with LPS or Pam3CSK4. ............................... 17 
ix 
Figure 17. BCG vaccination increased nonspecific production of monocyte-derived 
proinflammatory cytokines. .................................................................................................. 18 
Figure 18. BCG vaccination increases glucose consumption and lactate production in bovine 
trained monocytes. ................................................................................................................ 19 
Figure 19. BCG aerosol immunization does not alter the frequency or surface marker expression 
of bovine circulating monocytes. .......................................................................................... 20 
Figure 20. BCG vaccination induces long-term ‘trained’ phenotype in bovine PBMCs. ............ 21 




List of Tables 
Table 1. Reagents Flow cytometry ................................................................................................. 8 
Table 2 Flow cytometry reagents .................................................................................................. 12 





Putting together this defense required an amazing team of people. I am overcome with 
gratitude as I type each their names.  As I reflect on my past five years at KSTATE–one of which 
I spent in ISU–I’m struck by just how many people have helped me to get to this point.  
Thank you to my advisor and friend, Jodi, for offering me years of support, teaching with 
devotion, for listening, for giving me the time, space, and support to become a scientist.  There’s 
no way I finish my PhD without your guidance.  Thank you for being such a strong advocate for 
me.  I’m forever indebted; this work is my way of paying it forward.  
Thank you to my advisor in matters of education and life, Tona, for being my advocate in 
everything, everywhere, all the time.  The training to become an DVM/PhD is long and arduous 
but knowing you’re in my corner makes all the difference. I’m forever grateful.  
Thank you to my lab-partner and friend, Rachel. Having you as an extra pair of hands and 
another immunologist to bounce ideas off was invaluable to finishing up this work. 
KSTATE fosters a fantastic learning environment, and plenty of faculty and students 
outside my lab were instrumental in my development as a scientist—thank you all.  To my thesis 
research advisory committee—Mindy, Roman, Mwangi, and Barry—thank you for sitting through 
all my boring presentations and guiding me towards this point. I’d especially like to thank Ray for 
having a generous collaborative policy—your contributions into my work have been extremely 
valuable.  Your work provides the foundation for much of my own. 
I have amazing coworkers and research mentors, but I would not be here today without my 
family and friends, my support system. Too often, I rode the emotional rollercoaster after yet 
another failed experiment, but you all kept me going.  To all my friends in the graduate school, 
thank you for being there and providing an outlet to vent and to keep me motivated to train for the 
xii 
marathon.  To Ana and So Lee, I call you my scientific parents in crime. Thank you for being my 
emotional support through the tough times.  I love you both.  To all my friends back home: our 
friendships span decades and time zones.  I’m grateful to have you all in my life. 
Thank you to my mom and best friend.  I’m inspired to live by your values every day. 
You’ve raised me and helped me to become who I am today, and for that I am grateful beyond 
measure.  This work would not have gotten to the finish line without you.  I love you, Cuca.  
To my brother, father, and sister, words cannot express how much you mean to me.  To my 
nephews, Lorenzo and Mariano, for giving me a deeper purpose. To my grandmother, for being 
supportive and proud of everything I do–always. I love you. 
Thank you, my pets, Falcon and Rita, for keeping me company when I’m so far away from 
home.  I cherish our time together, and you two were so patient to give me the great length of time 
it took to complete this work.  I’m excited for our next adventure together.  
 




LIST OF ARTICLES  
Other work published but not included in this thesis.  
1. McGill JL, Rusk RA, Guerra-Maupome M, Briggs RE, Sacco RE. Bovine 
Gamma Delta T Cells Contribute to Exacerbated IL-17 Production in Response to 
Co-Infection with Bovine RSV and Mannheimia haemolytica. Plos One. (2016) 
11(3): e0151083. doi.org/10.1371/journal.pone.0151083 
2. McGill JL, Guerra-Maupome M, Schneider S. Prophylactic digoxin treatment 
reduces IL-17 production in vivo in the neonatal calf and moderates RSV-
associated disease. PLoS One. (2019);14(3): e0214407. 
doi.org/10.1371/journal.pone.0214407 
3. Guerra-Maupome, M., Palmer, M.V., McGill, J.L., Sacco, R.E. Neonatal calves 
as a model of human RSV infection. Vaccines. (2019) 20197;(1), 7. 
doi.org/10.3390/vaccines7010007. 
 
Other work under review but not included in this thesis 
1. McGill JL, Kelly MS, Guerra-Maupome M, Winkley E., Henningson J, 
Narasimhan B, Sacco RE. Vitamin A deficiency impairs the immune response to 
intranasal vaccination and RSV infection in neonatal calves. Journal of 
Immunology. (2019)  
2. Guerra-Maupome M, McGill JL. Gamma delta T cell function in ruminants. 




Chapter 1 - GENERAL INTRODUCTION AND BACKGROUND 
 
DISSERTATION ORGANIZATION 
This dissertation follows the organizational format in which each chapter is an independent 
manuscript that has been accepted or submitted.  These chapters follow the submission guidelines 
for the specific journals to which they were submitted.  An overview and literature review, which 
comprises further details related to the dissertation, are included in Chapter 1, part of which has 
will be published in Veterinary Clinics of North America: Food Animal Practice.  Chapter 2 has 
been submitted for publication in Immunohorizons. Chapter 3 has been submitted for publication 
in Scientific Reports. Chapter 4 has been published in Plos One. Chapter 5 encloses the general 





Mycobacteria are intracellular, slow-growing, aerobic, gram positive, rod-shaped bacteria.  
Mycobacterium bovis (M. bovis) is one of eight members of the Mycobacterium tuberculosis 
complex (Mtbc) (1).  Members of the Mtbc are characterized by high genetic homology, with 
99.9% similarity at the nucleotide level and identical 16S rRNA sequences; however, they differ 
in their hosts, phenotypes, and pathogenicity (2).  The mycobacterial cell wall is complex, 
consisting of peptidoglycolipids, cord factors and sulpholipids.  Unlike other gram-positive 
bacteria, members of the Mtbc do not retain the gram stain due to the structure of the cell wall.  
Mycobacteria are therefore identified as being acid-fast and are detected using the Ziehl-Nielsen 
stain.   
M. bovis is the causative agent of bovine TB in cattle (bTB) and zoonotic TB infection in 
humans (3).  BTB is a chronic infectious disease, characterized by granulomatous lesions localized 
primarily in the lower and upper respiratory tract, of cattle and a wide range of wildlife species.  
The disease is a cause of significant economic losses for the livestock industry, through the loss of 
animals to culling and the costs associated with disease testing and control (4).  BTB is also a 
major public health risk to populations in developing countries and is of increasing concern to 
communities living at the human–animal interface (4-6).  Thus, effective control of bTB may 
significantly impact human health.  However, despite improvements in disease control strategies, 
many countries’ efforts to eradicate are complicated by the presence of M. bovis infected wildlife 
species, which act as reservoirs of infection (4). 
Disease pathogenesis and the development of innate and adaptive immune response in 
cattle infected with M. bovis reflect many of the characteristics of M. tuberculosis infection in 
humans.  The discovery of these similarities has led to an appraisal of the benefits of collaborative 
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approaches between human and animal research (4, 7-9).  One significant outcome of these 
collaborative approaches was the current vaccine that is used against TB in humans, the attenuated 
M. bovis strain Bacille Calmette-Guerin (BCG) (4).  While the efficacy of the BCG vaccine in 
both cattle and humans is variable [reviewed in (4, 10)], neonatal vaccination in both species 
induces a significant degree of protective immunity (7, 11).  Moreover, BCG expresses antigens 
broadly overlapping with virulent M. bovis; thus, knowledge gained by the use of BCG in 
experimental studies is vital for developing novel vaccines strategies (12).   
 
 Immune response to M. bovis 
A range of complex factors such as animal genetics, age, nutritional status, the presence of 
other infections and the virulence of the particular strain is known to influence the host immune 
response to M. bovis.  Innate immune responses are important for recruiting immune cells and 
establishing early lesion formation; however, in many cases, these responses do little to limit 
infection and it is the adaptive cell-mediated immune (CMI) response that is essential for 
controlling the disease [reviewed (8, 13-16)].   
 
Innate immune response  
Pulmonary bTB infection is primarily transmitted through inhalation of aerosol droplets 
containing M. bovis (17).  Alveolar macrophages (AMs) are considered the major host cell for 
mycobacteria in vivo.  AMs have important effector functions that aid in the control and destruction 
of the invading bacteria.  Entry of M. bovis into macrophages is mediated by binding to 
macrophage surface receptors such as Toll-like receptors (TLR), complement receptors, C-type 
lectin receptors (CLRs), nucleotide‐binding oligomerization domain‐containing protein 2 (NOD2), 
and mannose receptors (18).  Once the bacteria are internalized, they are contained within 
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intracellular phagosomes.  Several strategies have been described in relation with mycobacterial 
survival within a host [reviewed in (19)].  For example, mycobacteria inhibit lysosome fusion by 
the intercalation of mycobacterial membrane lipids with endosomal membranes, leading to the 
phagosome arrest in maturation and preventing the vesicle from acidifying (20).  Infected 
macrophages are also impaired in their ability to produce Nitric Oxide (NO), TNFa, and IL-12 all 
of which are necessary for activation of the subsequent immune response.   
Once macrophage infection is established, other immune cells are recruited to the site of 
infection to confine the bacilli and prevent further spread by forming granulomas.  Granulomas 
are organized structures of immune cells that contain epithelioid or foamy macrophages, 
Langerhans-type multinucleated giant cells, lymphocytes, fibroblasts, and neutrophils (21).  Host-
pathogen interactions over the course of infection lead to changes in the immune cells recruited to 
the granuloma and the levels of immune mediators that are produced.  Granulomas form in the 
early stages of disease and are primarily comprised of macrophages, neutrophils and other innate-
like cells such as NK cells and γδ T cells.  The accumulation of macrophages and dendritic cells 
(DC) ultimately initiates the adaptive immune response, resulting in later recruitment of adaptive 
immune cells such as CD4 and CD8 T cells and B cells.   
Dendritic cells (DC) are important phagocytes that can ingest and harbor mycobacteria.  
Recognition of mycobacterial components by DCs occurs by interaction with CLRs, Dendritic 
Cell-Specific Intercellular adhesion molecule-3-Grabbing Non-integrin (DC-SIGN), and TLR 
receptors (22).  Murine studies have shown that effective anti-mycobacterial T cell responses are 
mediated by antigen transport to draining lymph nodes by migratory DC (23).  In particular, the 
most important role of DCs and macrophages is to initiate adaptive immune responses through the 
production of a wide array of cytokines in such as: TNFα, IL-1β, IL-6, IL-10, IL-12, IFNg, and 
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TGF-β (24, 25).  However, mycobacteria are capable of altering normal DC function, thus 
inhibiting these cells from inducing an effective subsequent adaptive immune response (26). 
Neutrophils are the most abundant white blood cell population in the peripheral blood and 
are among the first inflammatory cells to localize at the periphery of the granuloma (21, 27). 
Although neutrophils have been shown to have mycobacteriocidal activity in some hosts, this 
appears to depend on several host factors and the stage of infection [reviewed (28)].  However, 
neutrophils clearly participate in immunity to TB in other capacities.  Defective neutrophil 
functions or depletion of neutrophils exacerbates mycobacterial growth in different organs and 
reduces IFNγ levels and NO synthase activity (29), suggesting a protective role for neutrophils in 
host defense.  Activated neutrophils also influence innate and adaptive immune responses by 
acting like antigen presenting cells (APC), producing antimicrobial molecules, pro-inflammatory 
cytokines and chemokines such as TNFα and CXCL10 (30, 31).  However, a neutrophil-driven, 
interferon (IFN)-inducible gene profile in human patients with TB has been shown to correlate 
with clinical severity, suggesting that neutrophils may directly contribute to disease pathogenesis 
(32). 
Other innate immune cells, such as natural killer (NK) cells, also play a role in the innate 
response to M. bovis infection.  In calves, NK cells are present in higher numbers and are more 
functionally active compared to adults, and this appears to be important in the context of neonatal 
BCG vaccination (33).  NK cells recognize endogenous host molecules with altered expression 
due to cellular stress through a combination of stimulatory and inhibitory receptors.  In vitro, M. 
tuberculosis infected antigen presenting cells (APC) recruit NK cells and augment both their 
cytolytic activity and IFNγ release (23).  In vitro, bovine NK cells have been shown to serve as an 
early source IFNγ, which reduces BCG proliferation in infected macrophages (34-36).  Bovine NK 
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cells are also a source of perforin and granulysin that aids in the killing of infected cells, although 
these cells are not efficient at directly killing bacteria (8, 24).   
 
Adaptive immune responses  
Although innate immune responses are clearly essential for defense against TB infection, 
they are insufficient for the long-term control and prevention of the disease.  Protective immunity 
against Mycobacteria is ultimately dependent upon the initiation of the adaptive immune response.   
B lymphocytes are involved in TB granuloma maintenance in some species; however, only 
a small percentage of cattle infected with TB exhibit a measurable antibody response (37, 38).  In 
in vitro models of BCG infection, mycobacteria-specific antibodies have been shown to increase 
uptake and killing of BCG bacteria by neutrophils and macrophages (39).  In mice depletion of B 
cells results in exacerbated immunopathology and excessive neutrophil accumulation, which 
coincides with increased bacterial burden (39, 40).  However, humoral immunity and antibody 
mediated immunity is generally regarded as nonprotective against TB in all species (41, 42).   
Protective immunity against TB is dependent upon the interaction of T cells with infected 
macrophages.  Initiation of the mycobacteria–specific T cell response is delayed 12-15 days  after 
aerosol infection (43).  Such delay allows the pathogen an opportunity to establish a niche and to 
direct the ensuing immune response in favor of bacterial persistence and chronic immune 
stimulation (61).  It has been speculated that the delayed initiation of the acquired immune response 
by mycobacteria is a result of its slow growth and the relatively immunoprivileged state of the site 
of infection [reviewed (22)]. 
CD8 T cells, are often referred to as cytotoxic T lymphocytes (CTL).  Upon mycobacterial 
infection, CTLs produce IFNγ, granulysin, and perforin, and are capable of lysing infected 
macrophages and mycobacteria (44, 45).  In mice, CD8 T cells contribute to protection against 
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rapidly progressive M. tuberculosis infection; infected CD8 T cell–deficient mice succumb earlier 
than wild-type controls but later than CD4 T cell–deficient mice (46).  In calves, in vivo depletion 
of CD8 T cells in the early stages of M. bovis infection results in reduced IFNγ production and 
reduced pathology scores in the head draining lymph nodes compared to nondepleted calves, 
suggesting that CD8 cells play a role in bTB immunopathology(47).     
Control of TB infection requires CD4 T cells and is thought to be primarily mediated by 
IFNγ and TNFα, which activates macrophages and promotes their anti-microbial activities (48).  
Immune deficiencies affecting CD4 T cells (e.g., HIV infection) and IL-12/IFNγ /STAT1 signaling 
pathways result in more severe disease upon TB infection in humans (49, 50).  Furthermore, IFNγ 
production is depressed in whole-blood cultures from advanced TB patients (51).  However, 
despite the requirement for IFNγ in immunity to TB, its secretion by CD4 T cells is a poor correlate 
of protection (52, 53).  This is further demonstrated by studies in which, despite increasing the 
frequency of IFNγ producing CD4 T cells, protective immunity was not increased (54).  In some 
recent studies, it has been shown that polyfunctional T cells, in particular antigen-specific CD4 T 
cells producing a combination of IFNγ, IL-2, and/or TNFα, show greater association with 
protective immunity to TB than do IFNγ secreting monofunctional T cells (55).  Consistent with 
these observations, protection against M. bovis infection in cattle has been strongly correlated with 
a high frequency of polyfunctional CD4 T cells (55).  In humans, however, despite the expansion 
of polyfunctional T cells, the results obtained from a recent phase 2b vaccine trial in infants 
indicated no enhancement in protection (56). Thus, while CD4 T cells, and the cytokines they 
produce, are an essential component of the response to infection, their participation alone is not a 
biomarker indicative of protection against TB, further underscoring the need to engage other 
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components of the host immune system in protective responses against Mycobacterium infection 
(7, 8).   
 
 γδ T cells  
Gamma delta T cells have been identified in all vertebrate species examined thus far (57).  
Since they were first identified in 1980’s, a considerable effort has been made to understand their 
function and importance in human and animal health.  In mice and adult humans, γδ T cells exist 
as a relatively small proportion of the peripheral blood T cells (~1 - 5%), yet in epithelial tissues 
γδ T cells can represent nearly 40-50% of T cells (58).  In ruminants, γδ T cells constitute a major 
lymphocyte population in peripheral blood, epithelial tissues and sites of inflammation (59).  The 
high frequency (20-60%) of γδ T cells in ruminants, particularly in young animals, suggests an 
important role in host defense.   
Contrary to αβ T cells, γδ T cells can recognize a broad range of protein and non-protein 
ligands antigens [reviewed in (60)] without the presence of major histocompatibility complex 
(MHC).  Upon antigen recognition, γδ T are primed for rapid effector function that correlates with 
their defined tissue distribution, T cell receptor (TCR) gene expression and phenotype.  Identified 
γδ T cell functional responses include proinflammatory cytokine production (61-65), cytotoxicity 
(62, 66-68), antigen (Ag) presentation (63, 69), and a regulation of inflammatory processes (66, 
70, 71).   
Major differences between αβ and γδ T cells concern the specific anatomical sites where 
they localize, and the Ag recognized by the respective TCR molecules.  γδ T cells are capable of 
rearranging a diverse set of germline-encoded variable (V), diversity (D), and joining (J) gene 
segments during development to generate functional Ag receptors.  The overall repertoire of g or 
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d TCR gene segments available for recombination is much smaller than that seen for a or b TCR 
chains.  Diversity in the γδ TCR is increased by the potential to join several D-gene segments in 
multiple reading frames within a single δ-chain, in addition to N- and P-nucleotide addition during 
recombination (72).  Theoretically this increases the range of molecules that can be recognized by 
generating a particularly diverse set of CDR3 sequences.  They also show canonical pairing of 
chains that incorporate the product of a particular Vγ gene segment with chains incorporating the 
product of a particular Vδ gene segment. As a result, the resident population of γδ T cells within 
an organ, such as the skin or gut, can be nearly homogeneous with regard to TCR expression (58). 
 
Ruminant γδ T cell subsets 
A large proportion of ruminant γδ T cells express WC1, a transmembrane glycoprotein and 
member of the scavenger receptor cysteine rich (SRCR).  WC1 is thought to act as pathogen 
recognition receptor (PRR) and/or co-stimulatory molecule (73, 74).  Although genes have been 
identified in humans and mice which share some homology with WC1, the receptor is not 
expressed in species other than ruminants and pigs (75).  In cattle, the WC1 molecule is encoded 
by at least 13 genes.  Bovine WC1+ γδ T cells are CD2- CD4- CD8- and are a predominant subset 
in peripheral blood.  In contrast, the WC1neg γδ T cell population is most numerous in the spleen, 
uterus, intestinal mucosa and mesenteric lymph nodes (LNs), and the majority express CD2 and 
CD8 (76, 77).  WC1+ γδ T cells in cattle can be further divided into three defined populations, 
differentiated by the WC1 genes they express and the pathogens to which they respond: WC1.1+, 
WC1.2+ and WC1.3+ (78, 79).  WC1.3+ cells are contained within the WC1.2+ subset.  The bovine 
WC1+ and WC1neg γδ T cell populations use different families of TCR genes, home to different 
tissue locations and thus, have distinct immunological roles in the ruminant immune system [(77, 
79) and reviewed in (Guerra-Maupome & McGill, manuscript under review)]. 
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γδ T cells and the immune response to M. bovis  
Early after mycobacterial infection, γδ T cells undergo dynamic changes in frequency and 
activation status in the peripheral blood and accumulate in the lungs and the regional lymph nodes, 
suggesting an important role in the early stages of infection (9-14).  Infection with M. bovis elicits 
vigorous in vitro proliferative responses, and robust IFNγ production by γδ T cells in response to 
protein and nonprotein Ags from Mycobacterium (22, 80-83), indicating that γδ T cells have the 
capacity to respond specifically and directly to mycobacteria (15-20).  BCG vaccination and 
virulent M. bovis infection also induce increases in circulating WC1+ γδ T cells, and these cells 
have with the capacity to lyse autologous M. bovis-infected monocytes (68, 84).   
As mentioned previously, natural M. bovis infection occurs as a result of pathogen invasion 
from airborne transmission.  Therefore, recruiting immune cells to the lungs is required for 
controlling the infection.  One of the remarkable immune features of mycobacterial-specific γδ T 
cells is their capacity to traffic to lungs and mucosal surfaces in the early stages of disease. γδ T 
cells are amongst the first T cells to infiltrate early M. bovis granuloma lesions, arriving prior to 
CD4 T cells (85).  WC1.1+. WC1.2+ and WC1neg γδ T cells can be found accumulating in the 
lymphoid mantle surrounding M. bovis granulomas in the lungs (82).  In the developing granuloma, 
γδ T cells can serve as a major source of the pro-inflammatory cytokine, IL-17, which indirectly 
mediates neutrophil recruitment (86, 87).  Depletion of γδ T cells prior to virulent M. bovis 
infection does not significantly alter disease pathology, but does result in increased production of 
antigen-specific IL-4 and impaired lymphocyte proliferative responses, suggesting alterations in 
the Th1 bias of the immune response following infection (27).  
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Memory-like responses of γδ T cells to Mycobacterial infection  
While generally considered cells of the innate immune system, adaptive and memory-like 
features have been described for γδ T cells in the context of mycobacterial infection [reviewed in 
(88)].  In humans, BCG vaccination induces a population of γδ T cells that proliferate in response 
to in vitro stimulation with mycobacterial components (89).  Interestingly, a clear memory-type 
response of Vγ2Vδ2 T cells can be detected soon after BCG reinfection and the magnitude of this 
expansion is 2–9-fold greater than that seen during primary BCG infection (89).  In non-human 
primates, Vγ9Vδ2 T cells expand >25-fold in response to primary TB vaccination and display an 
accelerated recall response after a secondary M. tb challenge, which correlates with protection 
against fatal TB (90).  Primary and recall expansions of γδ T cells are also seen following M. bovis 
and M. tb aerosol challenges (27, 90-93).  Importantly, the capacity to rapidly expand Vγ9Vδ2 
upon challenge coincides with reduced M. tb burdens and protection against fatal tuberculosis in 
BCG-vaccinated macaques (94).  Administration of phosphoantigens and IL-2 induces marked 
expansion and pulmonary trafficking/accumulation of phosphoantigen-specific Vγ2Vδ2 T cells, 
resulting in significantly reduced bacterial burdens and decreased lung pathology upon subsequent 
M. tb challenge (95).  These results suggest that γδ T cells, like αβ T cells, can acquire functional 
memory-like traits and participate in protection against mycobacterial infections.   
Phenotypic analyses have shown that human γδ T cells can be differentiated into effector 
or memory phenotypes based on their expression of the surface molecules CD45RA and CD27 
(96, 97).  Effector/memory T cells are CD45RAneg and participate in recall responses to antigen 
(98-101).  Bovine CD45RA and CD45RB isoforms are not yet defined; thus, CD45R is used as a 
marker for naïve lymphocytes in cattle (101).  CD27 is a member of the tumor necrosis factor 
(TNF) family, known to be modulated in human, mice and pig CD4 and γδ T cells in response to 
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antigenic stimulation (96, 102, 103).  CD27 expression has also been identified in bovine T cells, 
with an almost identical cellular distribution to that reported in humans (104).  
Naïve CD45RA+ CD27+ γδ T cells represent ~10-20% of the circulating population in 
healthy adult humans.  CD45RA- CD27+ central memory (TCM) cells are more plentiful in the blood 
and exhibit robust proliferative capacity, but limited effector functions.  CD45RA- CD27- effector 
memory (TEM) and CD45RA+ CD27- (TEMRA) γδ T cells are generally recognized to be fully 
differentiated subsets.  Both TEM and TEMRA cells have low proliferative capacities but exhibit 
robust effector functions.  Consistent with their differential homing capacity, certain chemokine 
receptors are also useful for classifying functional γδ T cell subsets (105).  The expression of the 
homing receptors CXCR3, CCR5 and CD62L have been used to differentiate effector and memory 
subsets (106).  The TEM pool expresses high levels of CXCR3 and CCR5 and loses expression of 
the lymph node homing receptors CD62L and CCR7.  TCM cells may express CXCR3 and CCR5 
but retain expression of CD62L (96).   
Interestingly, serious TB disease results in reduced γδ T cell effector functions in the 
periphery (96). Consistent with this observation, there is a progressive loss of CD27neg TEM and 
TEMRA γδ T cell subsets from the peripheral blood of patients with active TB (97, 107).  The 
implications of these changes on control of the disease is not well defined, and there are limitations 
for assessing the biological significance of γδ T cells in the response to TB in humans.  However, 
cattle have abundant γδ T cells in the periphery and, as a physiologic model of TB infection, can 
be applied to questions of γδ T cell biology during Mycobacterium infection (4, 7, 12).  To date 
there are few published reports investigating γδ T cell differentiation in ruminants, or the impact 
of bTB infection on this process.  Improved characterization of γδ T cell effector and memory-like 
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responses induced during mycobacterial infection will contribute to better strategies for harnessing 
the γδ T cell response in protection against TB for both humans and animals. 
   
 Innate immune memory 
While dogma states that the innate immune system responds nonspecifically, and cannot 
improve following pathogen exposure, recent evidence has challenged that concept.  It has long 
been known that that previous exposure to live vaccines such as M. bovis BCG, measles and yellow 
fever, as well as to some microbial components of pathogens (33, 108-113), reduces the risk of 
childhood mortality due to prevention of unrelated illnesses, such as sepsis, diarrhea and 
respiratory infections [(26, 114-116) and reviewed (117, 118)].  This nonspecific disease resistance 
has been shown to be independent of the adaptive response, and is instead mediated by  enhanced 
memory-like responses of the innate immune system, a hypothesis that has been termed ‘trained’ 
innate immunity (119, 120).   
In humans, BCG vaccination leads to an enhanced production of the monocyte-derived 
proinflammatory cytokines, TNFa and IL-6, in response to unrelated bacterial and fungal 
pathogens (C. albicans, Staphylococcus aureus) (112); and superior NK cell activity (111).  
Moreover, in neonates, intradermal BCG vaccination at birth influences the responses to common 
vaccine antigens at the systemic level, which appears to be mediated through differential activation 
of APCs, leading to enhanced activation of T lymphocytes (121).  Similarly, compared with 
unvaccinated babies, cord blood monocytes from BCG vaccinated infants show increased 
expression of granulysin and perforin upon stimulation (122).  
Evidence that trained immunity mediates the nonspecific protective effects seen after BCG 
vaccination came from proof-of-principle experimental studies in rodents.  In these studies, BCG 
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vaccination of severe combined immunodeficiency (SCID) or recombination-activating gene 1 
(rag1)-deficient mice, strains which are devoid of an adaptive immune system, induced protection 
against subsequent lethal Candida albicans (C. albicans) infection via a mechanism that was 
shown to require macrophages and proinflammatory cytokine production, both prototypical innate 
immune components (112, 123, 124).  Mice vaccinated with BCG also show increased resistance 
to malaria infection, which is associated with increased transcription of antimicrobial proteins 
compared with nonvaccinated mice (125). 
Trained immunity differs from adaptive memory for many aspects, including the lack of 
gene rearrangements, the involvement of epigenetic reprogramming, the type of cells involved 
(innate cells vs. T and B lymphocytes), and the receptors engaged in pathogen/antigen recognition 
[germline-encoded pattern-recognition receptors (PRR) vs. antigen-specific T cell and B cell 
receptors product of somatic recombination at the V(D)J locus] (33, 108-113, 119, 120, 124, 126). 
Epidemiological studies in children have shown that BCG vaccination induces nonspecific 
protection for at least the duration of early childhood (127).  Considering the short half-life of 
circulating monocytes, this suggests that the epigenetic reprogramming occurs in the bone marrow 
progenitors (113, 128). In an early study, the enhanced functional status of ‘trained monocytes’ 
was NOD2 dependent, and the increased gene expression of key proinflammatory cytokines was 
due to increased H3K4 trimethylation (112).  Further mechanistic studies have since confirmed 
that trained immunity can be mediated by epigenetic modifications, including histone acetylation 
and methylation and modulation of miRNAs, which can be shaped by environmentally induced 
metabolic changes (112, 124, 126).  Innate memory in rodents seems to be at least in part dependent 
on cellular metabolism, as the phenotype is correlated with a shift toward aerobic glycolysis and 
chemical inhibition of the AKT/mammalian target of rapamycin (mTOR)/hypoxia induced factor 
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1α (HIF1α) pathway blocks training (129, 130).  Subsequent studies in human monocytes have 
identified a similar metabolic switch after BCG priming that involves distinct histone methylations 
at the H3K4 mark, with chromatin remodeling at a subset of cytokine promoters that lead to 
transcriptional programs associated with genes of the mTOR pathway (131).  These metabolic 
changes result in differential gene expression and cell physiology leading to increased innate 
immune cells’ capacity to respond to stimulation (112, 124, 126). 
The nonspecific protection afforded by parenteral administration of BCG is increasingly 
appreciated as an aspect of innate immunity that can be exploited to enhance resistance against 
TB, as well as other pathogens of consequence [reviewed (132)].  In the context of TB, a ‘trained’ 
innate immune system may provide an immunological advantage in the extended time period 
before the adaptive immune response is generated, thus promoting early containment of the bacilli.  
Experiments aimed at understanding the mechanisms of innate immune training and identifying 
approaches for promoting enhanced innate resistance to TB and other respiratory infections are 
expected to significantly advance our ability to prevent and control infections in humans and 
animals. 
 
 Concluding remarks  
There is a knowledge gap in our understanding of what constitutes a protective immune 
response to TB infection or vaccination.  It is of pivotal importance to look beyond assumptions 
that Th1 cells and their cytokine signatures as cornerstones for protection against TB.  The 
evidence presented in this literature review highlights the importance of analyzing alternative cells 
and immune components to better define the mechanisms of host defense against TB.  These 
determinants may include mechanisms of innate ‘training’ that are IFNγ independent or may 
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emanate from unconventional T cell memory, such as that involving γδ T cells (Fig. 1).  Study of 
the natural immune response to M. bovis in the bovine model is a useful strategy for uncovering 
the correlates of protection that will be essential for the development of improved intervention 




Figure 1. Determinants of protection against Mycobacteria 
Protective immunity is dependent on the interactions between innate and adaptive compartments 
of the immune system. CD4 and CD8 T cells exhibit effector and memory function via secretion 
of cytokines and/or cytolysis of infected cells.  Other immune cells, like NK cells, Neutrophils and 
DC (not pictured), are also reported to play a role in protective immunity via secretion of 
inflammatory cytokines, and cytotoxic T cell function.  γδ T cells exhibit effector/memory-like 
function via secretion of IFNγ, cytotoxicity, etc. “Trained immunity”, a key feature of the innate 
immune system is mediated through epigenetic programming, may also play a role in imprinting 
the innate cells towards an enhanced response to secondary antigenic challenge and thereby 

























1. Smith NH, Hewinson RG, Kremer K, Brosch R, Gordon SV. Myths and misconceptions: 
the origin and evolution of Mycobacterium tuberculosis. Nat Rev Microbiol. 2009;7(7):537-44. 
2. Brosch R, Gordon SV, Marmiesse M, Brodin P, Buchrieser C, Eiglmeier K, et al. A new 
evolutionary scenario for the Mycobacterium tuberculosis complex. Proc Natl Acad Sci U S A. 
2002;99(6):3684-9. 
3. Organization WH. Global tuberculosis report 2018. 2018. 
4. Waters WR, Palmer MV, Buddle BM, Vordermeier HM. Bovine tuberculosis vaccine 
research: historical perspectives and recent advances. Vaccine. 2012;30(16):2611-22. 
5. Muller B, Durr S, Alonso S, Hattendorf J, Laisse CJ, Parsons SD, et al. Zoonotic 
Mycobacterium bovis-induced tuberculosis in humans. Emerg Infect Dis. 2013;19(6):899-908. 
6. Schiller I, Oesch B, Vordermeier HM, Palmer MV, Harris BN, Orloski KA, et al. Bovine 
tuberculosis: a review of current and emerging diagnostic techniques in view of their relevance 
for disease control and eradication. Transbound Emerg Dis. 2010;57(4):205-20. 
7. Endsley JJ, Waters WR, Palmer MV, Nonnecke BJ, Thacker TC, Jacobs WR, Jr., et al. 
The calf model of immunity for development of a vaccine against tuberculosis. Vet Immunol 
Immunopathol. 2009;128(1-3):199-204. 
8. Waters WR, Palmer MV, Thacker TC, Davis WC, Sreevatsan S, Coussens P, et al. 
Tuberculosis immunity: opportunities from studies with cattle. Clin Dev Immunol. 
2011;2011:768542. 
9. Buddle BM, Skinner MA, Wedlock DN, de Lisle GW, Vordermeier HM, Glyn Hewinson 
R. Cattle as a model for development of vaccines against human tuberculosis. Tuberculosis 
(Edinb). 2005;85(1-2):19-24. 
10. Buddle BM, Wedlock DN, Denis M, Vordermeier HM, Hewinson RG. Update on 
vaccination of cattle and wildlife populations against tuberculosis. Vet Microbiol. 2011;151(1-
2):14-22. 
11. Lopez-Valencia G, Renteria-Evangelista T, Williams Jde J, Licea-Navarro A, Mora-Valle 
Ade L, Medina-Basulto G. Field evaluation of the protective efficacy of Mycobacterium bovis 
BCG vaccine against bovine tuberculosis. Res Vet Sci. 2010;88(1):44-9. 
12. Buddle BM, Pollock JM, Skinner MA, Wedlock DN. Development of vaccines to control 
bovine tuberculosis in cattle and relationship to vaccine development for other intracellular 
pathogens. Int J Parasitol. 2003;33(5-6):555-66. 
13. McNair J, Welsh MD, Pollock JM. The immunology of bovine tuberculosis and 
progression toward improved disease control strategies. Vaccine. 2007;25(30):5504-11. 
19 
14. Pollock JM, Welsh MD, McNair J. Immune responses in bovine tuberculosis: towards 
new strategies for the diagnosis and control of disease. Vet Immunol Immunopathol. 
2005;108(1-2):37-43. 
15. Pollock JM, McNair J, Welsh MD, Girvin RM, Kennedy HE, Mackie DP, et al. Immune 
responses in bovine tuberculosis. Tuberculosis (Edinb). 2001;81(1-2):103-7. 
16. Siddiqui N, Price S, Hope J. BCG vaccination of neonatal calves: potential roles for 
innate immune cells in the induction of protective immunity. Comp Immunol Microbiol Infect 
Dis. 2012;35(3):219-26. 
17. Neill SD, Pollock JM, Bryson DB, Hanna J. Pathogenesis of Mycobacterium bovis 
infection in cattle. Vet Microbiol. 1994;40(1-2):41-52. 
18. Glatzel A, Wesch D, Schiemann F, Brandt E, Janssen O, Kabelitz D. Patterns of 
chemokine receptor expression on peripheral blood gamma delta T lymphocytes: strong 
expression of CCR5 is a selective feature of V delta 2/V gamma 9 gamma delta T cells. J 
Immunol. 2002;168(10):4920-9. 
19. Philips JA, Ernst JD. Tuberculosis pathogenesis and immunity. Annu Rev Pathol. 
2012;7:353-84. 
20. Russell DG. Mycobacterium tuberculosis and the intimate discourse of a chronic 
infection. Immunol Rev. 2011;240(1):252-68. 
21. Palmer MV, Waters WR, Thacker TC. Lesion development and immunohistochemical 
changes in granulomas from cattle experimentally infected with Mycobacterium bovis. Vet 
Pathol. 2007;44(6):863-74. 
22. Maue AC, Waters WR, Davis WC, Palmer MV, Minion FC, Estes DM. Analysis of 
immune responses directed toward a recombinant early secretory antigenic target six-kilodalton 
protein-culture filtrate protein 10 fusion protein in Mycobacterium bovis-infected cattle. Infect 
Immun. 2005;73(10):6659-67. 
23. Marino S, Pawar S, Fuller CL, Reinhart TA, Flynn JL, Kirschner DE. Dendritic cell 
trafficking and antigen presentation in the human immune response to Mycobacterium 
tuberculosis. J Immunol. 2004;173(1):494-506. 
24. Fenton MJ, Vermeulen MW. Immunopathology of tuberculosis: roles of macrophages 
and monocytes. Infect Immun. 1996;64(3):683-90. 
25. Arts RJ, Blok BA, van Crevel R, Joosten LA, Aaby P, Benn CS, et al. Vitamin A induces 
inhibitory histone methylation modifications and down-regulates trained immunity in human 
monocytes. J Leukoc Biol. 2015;98(1):129-36. 
26. Hollm-Delgado MG, Stuart EA, Black RE. Acute lower respiratory infection among 
Bacille Calmette-Guerin (BCG)-vaccinated children. Pediatrics. 2014;133(1):e73-81. 
20 
27. Kennedy HE, Welsh MD, Bryson DG, Cassidy JP, Forster FI, Howard CJ, et al. 
Modulation of immune responses to Mycobacterium bovis in cattle depleted of WC1(+) gamma 
delta T cells. Infect Immun. 2002;70(3):1488-500. 
28. Lowe DM, Redford PS, Wilkinson RJ, O'Garra A, Martineau AR. Neutrophils in 
tuberculosis: friend or foe? Trends Immunol. 2012;33(1):14-25. 
29. Pedrosa J, Saunders BM, Appelberg R, Orme IM, Silva MT, Cooper AM. Neutrophils 
play a protective nonphagocytic role in systemic Mycobacterium tuberculosis infection of mice. 
Infect Immun. 2000;68(2):577-83. 
30. Wang J, Zhou X, Pan B, Yang L, Yin X, Xu B, et al. Investigation of the effect of 
Mycobacterium bovis infection on bovine neutrophils functions. Tuberculosis (Edinb). 
2013;93(6):675-87. 
31. Seiler P, Aichele P, Bandermann S, Hauser AE, Lu B, Gerard NP, et al. Early granuloma 
formation after aerosol Mycobacterium tuberculosis infection is regulated by neutrophils via 
CXCR3-signaling chemokines. Eur J Immunol. 2003;33(10):2676-86. 
32. Berry MP, Graham CM, McNab FW, Xu Z, Bloch SA, Oni T, et al. An interferon-
inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature. 
2010;466(7309):973-7. 
33. Sun JC, Beilke JN, Lanier LL. Adaptive immune features of natural killer cells. Nature. 
2009;457(7229):557-61. 
34. Portevin D, Young D. Natural killer cell cytokine response to M. bovis BCG Is 
associated with inhibited proliferation, increased apoptosis and ultimate depletion of 
NKp44(+)CD56(bright) cells. PLoS One. 2013;8(7):e68864. 
35. Denis M, Keen DL, Parlane NA, Storset AK, Buddle BM. Bovine natural killer cells 
restrict the replication of Mycobacterium bovis in bovine macrophages and enhance IL-12 
release by infected macrophages. Tuberculosis (Edinb). 2007;87(1):53-62. 
36. Alvarez AJ, Endsley JJ, Werling D, Mark Estes D. WC1(+) gammadelta T cells 
indirectly regulate chemokine production during mycobacterium bovis infection in SCID-bo 
mice. Transbound Emerg Dis. 2009;56(6-7):275-84. 
37. Johnson JE, Gonzales RA, Olson SJ, Wright PF, Graham BS. The histopathology of fatal 
untreated human respiratory syncytial virus infection. Mod Pathol. 2007;20(1):108-19. 
38. Tsai MC, Chakravarty S, Zhu G, Xu J, Tanaka K, Koch C, et al. Characterization of the 
tuberculous granuloma in murine and human lungs: cellular composition and relative tissue 
oxygen tension. Cell Microbiol. 2006;8(2):218-32. 
39. de Valliere S, Abate G, Blazevic A, Heuertz RM, Hoft DF. Enhancement of innate and 
cell-mediated immunity by antimycobacterial antibodies. Infect Immun. 2005;73(10):6711-20. 
21 
40. Taylor G, Wyld S, Valarcher JF, Guzman E, Thom M, Widdison S, et al. Recombinant 
bovine respiratory syncytial virus with deletion of the SH gene induces increased apoptosis and 
pro-inflammatory cytokines in vitro, and is attenuated and induces protective immunity in calves. 
J Gen Virol. 2014;95(Pt 6):1244-54. 
41. Thoen CO, Kaplan B, Thoen TC, Gilsdorf MJ, Shere JA. Zoonotic tuberculosis. A 
comprehensive ONE HEALTH approach. Medicina (B Aires). 2016;76(3):159-65. 
42. Pollock JM, Neill SD. Mycobacterium bovis infection and tuberculosis in cattle. Vet J. 
2002;163(2):115-27. 
43. Chackerian AA, Alt JM, Perera TV, Dascher CC, Behar SM. Dissemination of 
Mycobacterium tuberculosis is influenced by host factors and precedes the initiation of T-cell 
immunity. Infect Immun. 2002;70(8):4501-9. 
44. Skinner MA, Yuan S, Prestidge R, Chuk D, Watson JD, Tan PL. Immunization with heat-
killed Mycobacterium vaccae stimulates CD8+ cytotoxic T cells specific for macrophages 
infected with Mycobacterium tuberculosis. Infect Immun. 1997;65(11):4525-30. 
45. Buddle BM, Skinner MA, Wedlock DN, Collins DM, de Lisle GW. New generation 
vaccines and delivery systems for control of bovine tuberculosis in cattle and wildlife. Vet 
Immunol Immunopathol. 2002;87(3-4):177-85. 
46. Mogues T, Goodrich ME, Ryan L, LaCourse R, North RJ. The relative importance of T 
cell subsets in immunity and immunopathology of airborne Mycobacterium tuberculosis 
infection in mice. J Exp Med. 2001;193(3):271-80. 
47. Villarreal-Ramos B, McAulay M, Chance V, Martin M, Morgan J, Howard CJ. 
Investigation of the role of CD8+ T cells in bovine tuberculosis in vivo. Infect Immun. 
2003;71(8):4297-303. 
48. Cooper AM. Cell-mediated immune responses in tuberculosis. Annu Rev Immunol. 
2009;27:393-422. 
49. Diedrich CR, Flynn JL. HIV-1/mycobacterium tuberculosis coinfection immunology: 
how does HIV-1 exacerbate tuberculosis? Infect Immun. 2011;79(4):1407-17. 
50. Cooper AM, Solache A, Khader SA. Interleukin-12 and tuberculosis: an old story 
revisited. Curr Opin Immunol. 2007;19(4):441-7. 
51. Hirsch CS, Toossi Z, Othieno C, Johnson JL, Schwander SK, Robertson S, et al. 
Depressed T-cell interferon-gamma responses in pulmonary tuberculosis: analysis of underlying 
mechanisms and modulation with therapy. J Infect Dis. 1999;180(6):2069-73. 
52. Mittrucker HW, Steinhoff U, Kohler A, Krause M, Lazar D, Mex P, et al. Poor 
correlation between BCG vaccination-induced T cell responses and protection against 
tuberculosis. Proc Natl Acad Sci U S A. 2007;104(30):12434-9. 
22 
53. Majlessi L, Simsova M, Jarvis Z, Brodin P, Rojas MJ, Bauche C, et al. An increase in 
antimycobacterial Th1-cell responses by prime-boost protocols of immunization does not 
enhance protection against tuberculosis. Infect Immun. 2006;74(4):2128-37. 
54. Skinner MA, Ramsay AJ, Buchan GS, Keen DL, Ranasinghe C, Slobbe L, et al. A DNA 
prime-live vaccine boost strategy in mice can augment IFN-gamma responses to mycobacterial 
antigens but does not increase the protective efficacy of two attenuated strains of Mycobacterium 
bovis against bovine tuberculosis. Immunology. 2003;108(4):548-55. 
55. Maggioli MF, Palmer MV, Thacker TC, Vordermeier HM, McGill JL, Whelan AO, et al. 
Increased TNF-alpha/IFN-gamma/IL-2 and Decreased TNF-alpha/IFN-gamma Production by 
Central Memory T Cells Are Associated with Protective Responses against Bovine Tuberculosis 
Following BCG Vaccination. Front Immunol. 2016;7:421. 
56. Tameris MD, Hatherill M, Landry BS, Scriba TJ, Snowden MA, Lockhart S, et al. Safety 
and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with 
BCG: a randomised, placebo-controlled phase 2b trial. Lancet. 2013;381(9871):1021-8. 
57. Hayday AC. [gamma][delta] cells: a right time and a right place for a conserved third 
way of protection. Annu Rev Immunol. 2000;18:975-1026. 
58. Nielsen MM, Witherden DA, Havran WL. gammadelta T cells in homeostasis and host 
defence of epithelial barrier tissues. Nat Rev Immunol. 2017;17(12):733-45. 
59. Hein WR, Mackay CR. Prominence of gamma delta T cells in the ruminant immune 
system. Immunol Today. 1991;12(1):30-4. 
60. Born WK, Kemal Aydintug M, O'Brien RL. Diversity of gammadelta T-cell antigens. 
Cell Mol Immunol. 2013;10(1):13-20. 
61. Bonneville M, O'Brien RL, Born WK. Gammadelta T cell effector functions: a blend of 
innate programming and acquired plasticity. Nat Rev Immunol. 2010;10(7):467-78. 
62. Brown WC, Davis WC, Choi SH, Dobbelaere DA, Splitter GA. Functional and 
phenotypic characterization of WC1+ gamma/delta T cells isolated from Babesia bovis-
stimulated T cell lines. Cell Immunol. 1994;153(1):9-27. 
63. Collins RA, Sopp P, Gelder KI, Morrison WI, Howard CJ. Bovine gamma/delta TcR+ T 
lymphocytes are stimulated to proliferate by autologous Theileria annulata-infected cells in the 
presence of interleukin-2. Scand J Immunol. 1996;44(5):444-52. 
64. Jutila MA, Holderness J, Graff JC, Hedges JF. Antigen-independent priming: a 
transitional response of bovine gammadelta T-cells to infection. Anim Health Res Rev. 
2008;9(1):47-57. 
65. McGill JL, Nonnecke BJ, Lippolis JD, Reinhardt TA, Sacco RE. Differential chemokine 
and cytokine production by neonatal bovine gammadelta T-cell subsets in response to viral toll-
23 
like receptor agonists and in vivo respiratory syncytial virus infection. Immunology. 
2013;139(2):227-44. 
66. Chiodini RJ, Davis WC. The cellular immunology of bovine paratuberculosis: the 
predominant response is mediated by cytotoxic gamma/delta T lymphocytes which prevent 
CD4+ activity. Microb Pathog. 1992;13(6):447-63. 
67. Daubenberger CA, Taracha EL, Gaidulis L, Davis WC, McKeever DJ. Bovine 
gammadelta T-cell responses to the intracellular protozoan parasite Theileria parva. Infect 
Immun. 1999;67(5):2241-9. 
68. Skinner MA, Parlane N, McCarthy A, Buddle BM. Cytotoxic T-cell responses to 
Mycobacterium bovis during experimental infection of cattle with bovine tuberculosis. 
Immunology. 2003;110(2):234-41. 
69. Toka FN, Kenney MA, Golde WT. Rapid and transient activation of gammadelta T cells 
to IFN-gamma production, NK cell-like killing, and antigen processing during acute virus 
infection. J Immunol. 2011;186(8):4853-61. 
70. Hoek A, Rutten VP, Kool J, Arkesteijn GJ, Bouwstra RJ, Van Rhijn I, et al. 
Subpopulations of bovine WC1(+) gammadelta T cells rather than CD4(+)CD25(high) Foxp3(+) 
T cells act as immune regulatory cells ex vivo. Vet Res. 2009;40(1):6. 
71. Rhodes SG, Hewinson RG, Vordermeier HM. Antigen recognition and 
immunomodulation by gamma delta T cells in bovine tuberculosis. J Immunol. 
2001;166(9):5604-10. 
72. Clayton NS, Emery NJ. What do jays know about other minds and other times? In: 
Berthoz A, Christen Y, editors. Neurobiology of Umwelt: How Living Beings Perceive the 
World. Research and Perspectives in Neurosciences. Berlin: Springer-Verlag Berlin; 2009. p. 
109-23. 
73. Hsu H, Chen C, Nenninger A, Holz L, Baldwin CL, Telfer JC. WC1 is a hybrid 
gammadelta TCR coreceptor and pattern recognition receptor for pathogenic bacteria. J 
Immunol. 2015;194(5):2280-8. 
74. Wang F, Herzig CT, Chen C, Hsu H, Baldwin CL, Telfer JC. Scavenger receptor WC1 
contributes to the gammadelta T cell response to Leptospira. Mol Immunol. 2011;48(6-7):801-9. 
75. Crocker G, Sopp P, Parsons K, Davis WC, Howard CJ. Analysis of the gamma/delta T 
cell restricted antigen WC1. Vet Immunol Immunopathol. 1993;39(1-3):137-44. 
76. Baldwin CL, Sathiyaseelan T, Rocchi M, McKeever D. Rapid changes occur in the 
percentage of circulating bovine WC1(+)gamma delta Th1 cells. Res Vet Sci. 2000;69(2):175-
80. 
24 
77. Machugh ND, Mburu JK, Carol MJ, Wyatt CR, Orden JA, Davis WC. Identification of 
two distinct subsets of bovine gamma delta T cells with unique cell surface phenotype and tissue 
distribution. Immunology. 1997;92(3):340-5. 
78. Chen C, Herzig CT, Telfer JC, Baldwin CL. Antigenic basis of diversity in the 
gammadelta T cell co-receptor WC1 family. Mol Immunol. 2009;46(13):2565-75. 
79. Rogers AN, VanBuren DG, Hedblom E, Tilahun ME, Telfer JC, Baldwin CL. Function 
of ruminant gammadelta T cells is defined by WC1.1 or WC1.2 isoform expression. Vet 
Immunol Immunopathol. 2005;108(1-2):211-7. 
80. Welsh MD, Kennedy HE, Smyth AJ, Girvin RM, Andersen P, Pollock JM. Responses of 
bovine WC1(+) gammadelta T cells to protein and nonprotein antigens of Mycobacterium bovis. 
Infect Immun. 2002;70(11):6114-20. 
81. Smyth AJ, Welsh MD, Girvin RM, Pollock JM. In vitro responsiveness of gammadelta T 
cells from Mycobacterium bovis-infected cattle to mycobacterial antigens: predominant 
involvement of WC1(+) cells. Infection and immunity. 2001;69(1):89-96. 
82. McGill JL, Sacco RE, Baldwin CL, Telfer JC, Palmer MV, Waters WR. Specific 
recognition of mycobacterial protein and peptide antigens by gammadelta T cell subsets 
following infection with virulent Mycobacterium bovis. J Immunol. 2014;192(6):2756-69. 
83. Rhodes SG, Hewinson RG, Vordermeier HM. Antigen recognition and 
immunomodulation by gamma delta T cells in bovine tuberculosis. Journal of immunology. 
2001;166(9):5604-10. 
84. Olin MR, Hwa Choi K, Lee J, Molitor TW. Gammadelta T-lymphocyte cytotoxic activity 
against Mycobacterium bovis analyzed by flow cytometry. J Immunol Methods. 2005;297(1-
2):1-11. 
85. Plattner BL, Huffman EL, Hostetter JM. Gamma-delta T-cell responses during 
subcutaneous Mycobacterium avium subspecies paratuberculosis challenge in sensitized or naive 
calves using matrix biopolymers. Vet Pathol. 2013;50(4):630-7. 
86. Umemura M, Yahagi A, Hamada S, Begum MD, Watanabe H, Kawakami K, et al. IL-17-
mediated regulation of innate and acquired immune response against pulmonary Mycobacterium 
bovis bacille Calmette-Guerin infection. J Immunol. 2007;178(6):3786-96. 
87. Lockhart E, Green AM, Flynn JL. IL-17 production is dominated by gammadelta T cells 
rather than CD4 T cells during Mycobacterium tuberculosis infection. J Immunol. 
2006;177(7):4662-9. 
88. Chen ZW, Letvin NL. Vgamma2Vdelta2+ T cells and anti-microbial immune responses. 
Microbes Infect. 2003;5(6):491-8. 
25 
89. Hoft DF, Brown RM, Roodman ST. Bacille Calmette-Guerin vaccination enhances 
human gamma delta T cell responsiveness to mycobacteria suggestive of a memory-like 
phenotype. J Immunol. 1998;161(2):1045-54. 
90. Shen Y, Zhou D, Qiu L, Lai X, Simon M, Shen L, et al. Adaptive immune response of 
Vgamma2Vdelta2+ T cells during mycobacterial infections. Science. 2002;295(5563):2255-8. 
91. Koets A, Rutten V, Hoek A, van Mil F, Muller K, Bakker D, et al. Progressive bovine 
paratuberculosis is associated with local loss of CD4(+) T cells, increased frequency of gamma 
delta T cells, and related changes in T-cell function. Infect Immun. 2002;70(7):3856-64. 
92. Pollock JM, Pollock DA, Campbell DG, Girvin RM, Crockard AD, Neill SD, et al. 
Dynamic changes in circulating and antigen-responsive T-cell subpopulations post-
Mycobacterium bovis infection in cattle. Immunology. 1996;87(2):236-41. 
93. Price S, Davies M, Villarreal-Ramos B, Hope J. Differential distribution of WC1(+) 
gammadelta TCR(+) T lymphocyte subsets within lymphoid tissues of the head and respiratory 
tract and effects of intranasal M. bovis BCG vaccination. Vet Immunol Immunopathol. 
2010;136(1-2):133-7. 
94. Chen ZW. Protective immune responses of major Vgamma2Vdelta2 T-cell subset in M. 
tuberculosis infection. Curr Opin Immunol. 2016;42:105-12. 
95. Chen ZW, Letvin NL. Adaptive immune response of Vgamma2Vdelta2 T cells: a new 
paradigm. Trends Immunol. 2003;24(4):213-9. 
96. Dieli F, Poccia F, Lipp M, Sireci G, Caccamo N, Di Sano C, et al. Differentiation of 
effector/memory Vdelta2 T cells and migratory routes in lymph nodes or inflammatory sites. J 
Exp Med. 2003;198(3):391-7. 
97. Gioia C, Agrati C, Casetti R, Cairo C, Borsellino G, Battistini L, et al. Lack of CD27-
CD45RA-V gamma 9V delta 2+ T cell effectors in immunocompromised hosts and during active 
pulmonary tuberculosis. J Immunol. 2002;168(3):1484-9. 
98. Bembridge GP, MacHugh ND, McKeever D, Awino E, Sopp P, Collins RA, et al. 
CD45RO expression on bovine T cells: relation to biological function. Immunology. 
1995;86(4):537-44. 
99. Waters WR, Rahner TE, Palmer MV, Cheng D, Nonnecke BJ, Whipple DL. Expression 
of L-Selectin (CD62L), CD44, and CD25 on activated bovine T cells. Infect Immun. 
2003;71(1):317-26. 
100. Maggioli MF, Palmer MV, Thacker TC, Vordermeier HM, Waters WR. Characterization 
of effector and memory T cell subsets in the immune response to bovine tuberculosis in cattle. 
PLoS One. 2015;10(4):e0122571. 
101. Howard CJ, Sopp P, Parsons KR, McKeever DJ, Taracha EL, Jones BV, et al. Distinction 
of naive and memory BoCD4 lymphocytes in calves with a monoclonal antibody, CC76, to a 
26 
restricted determinant of the bovine leukocyte-common antigen, CD45. Eur J Immunol. 
1991;21(9):2219-26. 
102. Hintzen RQ, de Jong R, Lens SM, Brouwer M, Baars P, van Lier RA. Regulation of 
CD27 expression on subsets of mature T-lymphocytes. J Immunol. 1993;151(5):2426-35. 
103. Pepperberg IM. Avian cognition and social interaction: Fifty years of advances. Interact 
Stud. 2011;12(2):195-207. 
104. Sopp P, Howard CJ. Cross-reactivity of monoclonal antibodies to defined human 
leucocyte differentiation antigens with bovine cells. Vet Immunol Immunopathol. 1997;56(1-
2):11-25. 
105. Geginat J, Sallusto F, Lanzavecchia A. Cytokine-driven proliferation and differentiation 
of human naive, central memory and effector memory CD4+ T cells. Pathol Biol (Paris). 
2003;51(2):64-6. 
106. Qin S, Rottman JB, Myers P, Kassam N, Weinblatt M, Loetscher M, et al. The 
chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain 
inflammatory reactions. J Clin Invest. 1998;101(4):746-54. 
107. Meraviglia S, El Daker S, Dieli F, Martini F, Martino A. gammadelta T cells cross-link 
innate and adaptive immunity in Mycobacterium tuberculosis infection. Clin Dev Immunol. 
2011;2011:587315. 
108. Di Luzio NR, Williams DL. Protective effect of glucan against systemic Staphylococcus 
aureus septicemia in normal and leukemic mice. Infect Immun. 1978;20(3):804-10. 
109. Marakalala MJ, Williams DL, Hoving JC, Engstad R, Netea MG, Brown GD. Dectin-1 
plays a redundant role in the immunomodulatory activities of beta-glucan-rich ligands in vivo. 
Microbes Infect. 2013;15(6-7):511-5. 
110. Munoz N, Van Maele L, Marques JM, Rial A, Sirard JC, Chabalgoity JA. Mucosal 
administration of flagellin protects mice from Streptococcus pneumoniae lung infection. Infect 
Immun. 2010;78(10):4226-33. 
111. Kleinnijenhuis J, Quintin J, Preijers F, Joosten LA, Jacobs C, Xavier RJ, et al. BCG-
induced trained immunity in NK cells: Role for non-specific protection to infection. Clin 
Immunol. 2014;155(2):213-9. 
112. Kleinnijenhuis J, Quintin J, Preijers F, Joosten LA, Ifrim DC, Saeed S, et al. Bacille 
Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via 
epigenetic reprogramming of monocytes. Proc Natl Acad Sci U S A. 2012;109(43):17537-42. 
113. Kaufmann E, Sanz J, Dunn JL, Khan N, Mendonca LE, Pacis A, et al. BCG Educates 
Hematopoietic Stem Cells to Generate Protective Innate Immunity against Tuberculosis. Cell. 
2018;172(1-2):176-90 e19. 
27 
114. Aaby P, Roth A, Ravn H, Napirna BM, Rodrigues A, Lisse IM, et al. Randomized trial of 
BCG vaccination at birth to low-birth-weight children: beneficial nonspecific effects in the 
neonatal period? J Infect Dis. 2011;204(2):245-52. 
115. Biering-Sorensen S, Aaby P, Napirna BM, Roth A, Ravn H, Rodrigues A, et al. Small 
randomized trial among low-birth-weight children receiving bacillus Calmette-Guerin 
vaccination at first health center contact. Pediatr Infect Dis J. 2012;31(3):306-8. 
116. Levy O, Levy O. Ready to benefit from training: heterologous effects of early life 
immunization. Trans R Soc Trop Med Hyg. 2015;109(1):3-4. 
117. Blok BA, Arts RJ, van Crevel R, Benn CS, Netea MG. Trained innate immunity as 
underlying mechanism for the long-term, nonspecific effects of vaccines. J Leukoc Biol. 
2015;98(3):347-56. 
118. Netea MG, van Crevel R. BCG-induced protection: effects on innate immune memory. 
Semin Immunol. 2014;26(6):512-7. 
119. Netea MG, Quintin J, van der Meer JW. Trained immunity: a memory for innate host 
defense. Cell Host Microbe. 2011;9(5):355-61. 
120. Netea MG, Joosten LA, Latz E, Mills KH, Natoli G, Stunnenberg HG, et al. Trained 
immunity: A program of innate immune memory in health and disease. Science. 
2016;352(6284):aaf1098. 
121. Ota MO, Vekemans J, Schlegel-Haueter SE, Fielding K, Sanneh M, Kidd M, et al. 
Influence of Mycobacterium bovis bacillus Calmette-Guerin on antibody and cytokine responses 
to human neonatal vaccination. J Immunol. 2002;168(2):919-25. 
122. Semple PL, Watkins M, Davids V, Krensky AM, Hanekom WA, Kaplan G, et al. 
Induction of granulysin and perforin cytolytic mediator expression in 10-week-old infants 
vaccinated with BCG at birth. Clin Dev Immunol. 2011;2011:438463. 
123. van 't Wout JW, Poell R, van Furth R. The role of BCG/PPD-activated macrophages in 
resistance against systemic candidiasis in mice. Scand J Immunol. 1992;36(5):713-9. 
124. Quintin J, Saeed S, Martens JHA, Giamarellos-Bourboulis EJ, Ifrim DC, Logie C, et al. 
Candida albicans infection affords protection against reinfection via functional reprogramming 
of monocytes. Cell Host Microbe. 2012;12(2):223-32. 
125. Parra M, Liu X, Derrick SC, Yang A, Tian J, Kolibab K, et al. Molecular analysis of non-
specific protection against murine malaria induced by BCG vaccination. PLoS One. 
2013;8(7):e66115. 
126. Saeed S, Quintin J, Kerstens HH, Rao NA, Aghajanirefah A, Matarese F, et al. 
Epigenetic programming of monocyte-to-macrophage differentiation and trained innate 
immunity. Science. 2014;345(6204):1251086. 
28 
127. Stensballe LG, Nante E, Jensen IP, Kofoed PE, Poulsen A, Jensen H, et al. Acute lower 
respiratory tract infections and respiratory syncytial virus in infants in Guinea-Bissau: a 
beneficial effect of BCG vaccination for girls community based case-control study. Vaccine. 
2005;23(10):1251-7. 
128. Mitroulis I, Ruppova K, Wang B, Chen LS, Grzybek M, Grinenko T, et al. Modulation of 
Myelopoiesis Progenitors Is an Integral Component of Trained Immunity. Cell. 2018;172(1-
2):147-61 e12. 
129. Rodriguez-Prados JC, Traves PG, Cuenca J, Rico D, Aragones J, Martin-Sanz P, et al. 
Substrate fate in activated macrophages: a comparison between innate, classic, and alternative 
activation. J Immunol. 2010;185(1):605-14. 
130. Cheng SC, Quintin J, Cramer RA, Shepardson KM, Saeed S, Kumar V, et al. mTOR- and 
HIF-1alpha-mediated aerobic glycolysis as metabolic basis for trained immunity. Science. 
2014;345(6204):1250684. 
131. Arts RJ, Joosten LA, Netea MG. Immunometabolic circuits in trained immunity. Semin 
Immunol. 2016;28(5):425-30. 
132. Bhatt K, Verma S, Ellner JJ, Salgame P. Quest for correlates of protection against 
tuberculosis. Clin Vaccine Immunol. 2015;22(3):258-66. 
1 
 
Chapter 2 - Characterization of γδ T cell effector/memory subsets 
based on CD27 and CD45R expression in response to 
Mycobacterium bovis infection 
 
M. Guerra-Maupome*, M. V. Palmer	†, W. R. Waters† J. L. McGill* 
 
*Department of Veterinary Microbiology and Preventive Medicine, Iowa State University, Ames, 
IA, USA, †Infectious bacterial Diseases Research Unit, National Animal Disease Center, 
Agricultural Research Service, USDA, Ames, IA, USA. 
 
 ABSTRACT 
                                            
Tuberculosis (TB) remains a leading cause of death from infectious diseases worldwide. 
Mycobacterium bovis is the causative agent of bovine tuberculosis and zoonotic TB infection. γδ 
T cells are known to participate in the immune control of mycobacterial infections. Data in human 
and non-human primates suggest that mycobacterial infection regulates memory/effector 
phenotype and adaptive immune functions of γδ T cells. To date, the impact of M. bovis infection 
on bovine γδ T cells and their effector and memory differentiation remains unknown. In this study, 
we show for the first time that circulating γδ T cells from M. bovis infected cattle can be 
differentiated based on the expression of CD27, which is indicative of their capacity to respond to 
virulent M. bovis infection: CD27+ γδ T cells proliferated in response to M. bovis antigen and thus, 
may compose the adaptive γδ T cell compartment in cattle. We further show that bovine M. bovis-
specific γδ T cells express surface markers characteristic of TCM cells (CD45R- CD27+CD62Lhi) 
and that M. bovis-specific CD4 and γδ T cells both upregulate the expression of the tissue-homing 
receptors CXCR3 and CCR5 during infection. Our studies contribute significantly to our 
understanding of γδ T cell differentiation during TB infection and provide important insights into 
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the link between phenotypic and functional subsets in the bovine. Accurate characterization of γδ 
T cell effector and memory-like responses induced during mycobacterial infection will contribute 
to improved strategies for harnessing the γδ T cell response in protection against TB for both 




Tuberculosis (TB) is a leading cause of deaths related to an infectious disease worldwide 
(1). Mycobacterium bovis is a member of the M. tb complex and is the causative agent of bovine 
tuberculosis (bTB) and zoonotic TB infection.  Despite continuous efforts to control the disease, 
bTB is a significant cause of economic loss to the livestock industry, and a major public health 
risk to populations in developing countries (2-4).  Furthermore, bTB parallels human TB in several 
aspects of disease pathogenesis and the development of innate and adaptive immune responses (2, 
5, 6).  Thus, experimental studies of bTB are an excellent model to understand the immune 
response to M. tb infection in humans.  
Cell-mediated Th-1 immune responses are essential for controlling TB (7, 8).  Importantly, 
however, γδ T cells been shown to contribute to the immune response against TB.  M. bovis 
infection elicits a marked in vitro expansion and robust production of IFNγ by γδ T cells suggesting 
that bovine γδ T cells can mount memory-like responses upon restimulation (9-14).  Expression of 
cell surface memory markers CD45RA and CD27 is linked to functional segregation of γδ T cell 
memory subsets in non-human primates and humans (15, 16).  Naïve CD45RA+CD27+ γδ T cells 
represent ~10-20% of the circulating γδ T cell population in healthy human adults. CD45RA-
CD27+ central memory (TCM) γδ T cells are plentiful in peripheral blood and exhibit robust 
proliferative capacity, but limited effector functions.  TCM cells may express CXCR3 and CCR5 
but retain expression of CD62L (15).  CD45RA-CD27- effector memory (TEM) and 
CD45RA+CD27- effector memory RA (TEMRA) γδ T cells are generally recognized to be fully 
differentiated subsets.  They are infrequent in the blood, but abundant in tissues and sites of 
inflammation.  Both TEM and TEMRA cells have low proliferative capacity, but robust effector 
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functions.  Consistent with their differential homing capacity, the TEM pool expresses high levels 
of CXCR3 and CCR5 and loses expression of the lymph node homing receptors CD62L and CCR7.   
 In non-human primates, TEM Vγ9Vδ2 T cell expansion after a secondary M. tb challenge 
correlates with protection against fatal TB (17-19).  Importantly, however, serious TB disease 
results in a progressive loss of TEM and TEMRA γδ T cell subsets from the peripheral blood of 
humans with active TB (16, 20, 21).  The implications of these changes on control of the disease 
is not well defined, and there are limitations for assessing the biological significance of γδ T cells 
in the response to TB in humans.  Cattle have abundant γδ T cells and, as a physiologic model of 
TB infection, can be used to investigate γδ T cell biology in the context of Mycobacterium infection 
(2, 5, 22).  Currently, little is known about bovine γδ T cell differentiation during TB infection.  
Characterization of γδ T cell effector and memory-like responses induced by mycobacterial 
infection will contribute to our understanding of their role in protection against TB for both humans 
and animals.  To this end, cattle were infected via aerosol with virulent M. bovis and the effector 
and memory phenotypes of M. bovis-specific γδ T cells were examined by flow cytometry.  We 
hypothesized that infection with virulent M. bovis would result in the development of circulating 
memory-like γδ T cell populations.  M. bovis-specific γδ T cell effector and memory subsets were 
identified by their expression of CD27, CD45R and CD62L, and their expression of the activation 
and homing molecules CXCR3 and CCR5.  Our results show, that CD27 and CD45R can 
differentiate functional (i.e. proliferating), M. bovis-specific γδ T cell subsets in bovine peripheral 
blood and suggest that bovine γδ T cells differentiate into effector and memory T cell subsets that 




 MATERIALS AND METHODS 
 
ANIMAL USE ETHICS  
All animal studies were conducted according to federal and institutional guidelines and 
approved by the National Animal Disease Center Animal Care and Use committee and performed 
under appropriate project licenses.  A total of 16 Holstein steers (~3 months of age) were used in 
the following experiments.  Animals were housed in temperature- and humidity-controlled 
biosafety label-3 (BSL-3) containment rooms based upon treatment group, at the National Animal 




M. bovis strain 10-7428 isolated from a dairy farm in Colorado, was used for challenge 
inoculum.  Low passage (≤ 3) cultures were prepared using standard techniques in Middlebrook 
7H9 liquid media (Becton Dickinson, Franklin Lakes, NJ) supplemented with 10% oleic acid-
albumin-dextrose 67 complex (OADC) plus 0.05% Tween 80 (Sigma, St. Louis, Missouri).  
 
AEROSOL CHALLENGE PROCEDURES  
Treatment groups consisted of non-infected steers (n =6) and animals receiving 104 colony-
forming units (CFU) of M. bovis 10-7428 (n = 10).  M. bovis challenge inoculum was delivered to 
restrained calves by aerosol as described by Palmer et al. (23).  Briefly, inoculum was nebulized 
into a mask (Trudell Medical International, London, ON, Canada) covering the nostrils and mouth, 
allowing regular breathing and delivery of the bacterial inoculum to the upper and lower 
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respiratory tract via the nostrils.  The process continued until the inoculum, a 1 ml PBS wash of 
the inoculum tube, and an additional 2 ml PBS were delivered - a process taking ~10 min.  Strict 
biosafety protocols were followed to protect personnel from exposure to M. bovis throughout the 
study, including BSL-3 containment upon initiation of M. bovis challenge in animal rooms and 
standard laboratory practices for handling M. bovis cultures and samples from M. bovis-infected 
animals.  
 
PBMC ISOLATION  
Peripheral blood was drawn from the jugular vein into 2 × acid-citrate-dextrose solution. 
For peripheral blood mononuclear cell (PBMC) isolation, blood was diluted 1:1 in phosphate-
buffered saline (PBS) and cells were isolated from buffy coat fractions, and PBMCs were isolated 
by density centrifugation on Histopaque (Sigma).  PBMCs were collected and washed twice in 
PBS to remove platelets.  Residual red blood cells (RBC) were removed by adding RBC lysis 
buffer.  Finally, PBMCs were resuspended in complete Roswell Park Memorial Institute (RPMI)-
1640 medium (GIBCO, Grand Island) supplemented with 2 mM L-glutamine, 25 mM HEPES 
buffer, 1% antibiotic-antimycotic (Sigma, St. Louis, MO), 1% non-essential amino acids (Sigma), 
2% essential amino acids (Sigma), 1% sodium pyruvate (Sigma), 50 µM 2-mercaptoethanol 
(Sigma), and 10% (v/v) heat-inactivated fetal bovine sera (FBS).  
 
PROLIFERATION ASSAY 
To asses proliferation, PBMC were labeled using CellTrace Violet (Invitrogen, Carlsbad, 
CA) prior to cell culture following manufacturer’s instructions.  Briefly, freshy isolated cells were 
resuspended at 1×107 cells/mL in PBS containing 10 μM/ml of the CellTrace dye.  After gently 
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mixing, PBMCs were incubated for 20 min at 37°C in a water-bath.  Labeling was quenched by 
using an equal volume of FBS, and cells were washed three times with RPMI medium.  
Subsequently, cells (5x105 /well) were plated in round-bottom 96-well plate in duplicates, cultured 
for 6-days at 37°C, in the presence of 5% CO2, in the presence of M. bovis PPD (PPD-b, 200 
IU/mL, Prionics Ag, Schlieren, Switzerland), and recombinant ESAT-6/CFP-10 fusion protein (2 
µg/ml, LIONEX Diagnostics and Therapeutics GmbH).  Pokeweed mitogen (PWM, 1 µg/ml, 
Sigma) or complete RPMI medium were used as positive and negative control, respectively.  After 
six days, cells were surface stained (see Flow cytometry section) and analyzed for proliferation 
and surface marker expression by flow cytometry.  
 
FLOW CYTOMETRY  
Following the appropriate culture duration, cells were stained with primary and secondary 
monoclonal antibodies (mAbs) listed on Table I.  All incubation steps for staining were performed 
in FACS buffer (PBS with 10% FBS and 0.02% NA-azide) and incubated for 25 min at 4°C.  Cells 
were washed and fixed with BD FACS lysis buffer (BD Biosciences, Mountain View, CA) for 10 
min at room temperature, washed and resuspended in FACS buffer until analysis.  Samples were 
acquired using a BD LSR Fortessa flow cytometer (BD Biosciences).  Data were analyzed using 
Flowjo software (Tree Star Inc., San Carlos, CA). Electronic gates were set using Fluorescence 
minus one (FMO) controls.  
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 STATISTICAL ANALYSIS 
Results are expressed as mean ± standard errors of the mean.  Statistical significance was 
determined by one-way Analysis of Variance (ANOVA) followed by Bonferroni test, or Student’s 




Specificity, Source Secondary antibodies, Source 
ILA11 Bovine CD4, Washington State University Allophycocyanin
GB21A Bovine TCR1 delta chain, Washington State University APC-Cy7, SouthernBiotech
ILA116 Bovine CD45RO, Washington State University Alexa-fluor 488, Life Technologies
BAQ92A Bovine CD62L, Washington State University Allophycocyanin, Life technologies 
GC6A Bovine CD45R, Washington State University PercpCy5.5, Life technologies 
M-T271 Human CD27, Biolegend Allophycocyanin or Pe-Cy7, Life 
technologies 
G025H7 Human CXCR3 FITC, Biolegend Not applicable
HM-CCR5 Human CCR5 PerCP/Cy5.5, Biolegend Not applicable
Live Dead Aqua Dead cells, Invitrogen Not applicable
CellTrace Violet Not applicable, Life technologies Not applicable 
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 RESULTS 
Virulent M. bovis infection induces antigen-specific γδ T cell responses 
We and others have previously demonstrated that γδ T cells from virulent M. bovis-infected 
cattle respond to both the complex mycobacterial antigen, PPD-b, and to the specific protein 
antigen, ESAT-6/CFP-10 (10, 11, 24).  To corroborate our prior studies, animals were infected via 
aerosol inoculation with virulent M. bovis strain 10-7428 (n=10) or non-infected group (n=6).  
Following infection, PBMC were labeled with CellTrace dye and cultured for 6 days in the 
presence or absence of PPD-b or recombinant ESAT-6/CFP-10.  On day 6, cells were analyzed by 
flow cytometry for the frequency of γδ and CD4 T cells that divided in response to the 
mycobacterial antigens.  Representative proliferative responses of γδ and CD4 T cells following 
mycobacterial stimulation in vitro are depicted (Fig 2A and B).  Robust proliferative responses to 
PPD-b and ESAT-6/CFP-10 were observed by γδ T cells at 4 weeks post infection and persisted 
until at least 12-weeks post infection (Fig. 2C).  Consistent with prior reports, the mean CD4 T 
cell proliferative response to PPD-b and ESAT-6/CFP-10 peaked by 8 weeks post infection and 
persisted for at least 12 weeks post infection (Fig. 2D) (25).  Recall responses from both γδ and 
CD4 T cell populations were M. bovis-specific, as neither CD4 nor γδ T cells from non-infected 
cattle responded to the specific or complex mycobacterial antigens.   
 
Virulent M. bovis infection results in phenotypic changes on M. bovis-specific γδ and CD4 T 
cells  
Similar to humans, bovine naïve and memory CD4 T cells can be distinguished based on 
the expression of CD45 isoforms.  Naïve T cells express the high CD45RA isoform and upon 
antigenic recognition, T cells switch to the expression of the low CD45RO isoform (26, 27).  In 
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the bovine CD45RA and CD45RB isoforms are not yet defined; thus, CD45R is used as a marker 
for naïve lymphocytes in cattle (26).  To evaluate if CD45 isoform expression correlated with the 
bovine γδ T cell effector/memory population that responded to mycobacteria, we analyzed the 
CD45 phenotype of expanding M. bovis-specific γδ and CD4 T cells by flow cytometry following 
a 6-day in vitro restimulation with PPD-b (Fig. 3A).  In accordance with previous data (25, 28), 
the mycobacterial-driven proliferative responses to PPD-b were within the CD4+ CD45RO+ T cell 
subset, and the antigen-responsive cells downregulated CD45R expression compared to non-
responding cells (Fig. 3B).  In contrast to CD4 T cells, γδ T cells from M. bovis-infected cattle 
showed no significant changes in cell surface expression of CD45RO, between antigen-specific 
(proliferating) and non-responding γδ T cell populations.  However, antigen-responsive γδ T cells 
from infected cattle downregulated CD45R expression in response to PPD-b stimulation (Fig. 3C).  
Changes in expression of either CD45R or CD45RO were not detected in γδ T cells from 
noninfected animals after 6 days of culture.  From these results it can be concluded that CD45Rneg 
γδ and CD4 T cell subset participates in the in vitro recall responses against M. bovis.  
 
Peripheral γδ T cells from M. bovis infected cattle possess an activated/memory phenotype 
based on CD27 expression  
CD27, a costimulatory molecule, has been commonly used to identify stages of T cell 
differentiation (29).  In humans, two subsets of γδ T cells develop in response to antigen 
stimulation and are identified based upon their expression of CD27.  These subsets exhibit unique 
functions during mycobacterial infection that parallel the functions attributed to differentiated 
subsets of CD8 and CD4 T cells (15, 29).  Moreover, flow-cytometric analysis of CD27 expression 
on circulating MTB-specific T cells can help to discriminate disease progression (16, 30).   
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CD27 expression has been reported in bovine PBMCs, however, its expression on bovine 
γδ and CD4 T cells has not been determined (31).  Therefore, we performed ex vivo staining on 
PBMC from healthy cattle and observed that ~70% of CD4 T cells, and ~50% of γδ T cells express 
CD27 as measured by flow cytometry.  Following mitogen stimulation, both CD4 and γδ T cells 
CD27+ display significant higher clonogenic potential compared to CD27neg cells (Fig. 4).  Thus, 
CD27 expression was abundantly expressed on bovine peripheral T cells, and can be used to 
identify CD4 and γδ T cell subsets based on their capacity to proliferate (16, 32). 
 
CD27 expression on bovine γδ T cells identifies effector/memory subsets following virulent 
M. bovis infection 
To determine whether mycobacteria-specific T cells could be defined by the expression of 
CD27, we analyzed the expression on M. bovis-specific γδ and CD4 T cells following in vitro 
restimulation with PPD-b and ESAT-6/CFP-10 (Fig. 5A and B).  After 6 days in culture with 
PPD-b or ESAT-6/CFP-10, the majority of antigen-specific γδ T cells from M. bovis infected 
animals proliferated and upregulated expression of CD27 compared to non-responding γδ T cells 
in the same culture (Fig. 5A).  Similarly, CD27 expression was significantly greater on the antigen-
specific CD4 T cell population from M. bovis-infected animals compared to non-specific CD4 T 
cells in the same culture (Fig. 5B).  Both γδ and CD4 T cells from infected animals exhibited 
significant increases in CD27 expression compared cells from noninfected control calves.  Thus, 
from our results, increased expression of CD27 correlates with the capacity for bovine γδ T cells 
to proliferate in response to mycobacterial antigens, suggesting that bovine γδ T cell 
effector/memory phenotypes are consistent with those reported for human γδ T cells (16).  
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M. bovis-specific γδ T cells exhibit a TCM phenotype based on CD27 and CD45R expression 
Expression of CD45RA and CD27 defines four subsets of memory γδ T cells in humans 
(15).  Here, we sought to determine if the combination of both markers could be used to identify 
subsets of antigen-specific γδ T cells in cattle.  PBMCs from M. bovis-infected animals were 
stimulated in vitro with PPD-b for 6 days.  As shown in Fig. 6A, M. bovis-specific γδ T cells can 
be divided in four subsets: naïve (CD27+CD45R+), TCM (CD27+CD45R-), TEM (CD27-CD45R-), 
TEMRA (CD27-CD45R+) following in vitro stimulation with PPD-b.  CD27+CD45R- TCM γδ T cells 
exhibited the highest proliferative capacity following in vitro restimulation with mycobacterial 
antigens, followed by the CD27-CD45R- TEM γδ T cell subset (Fig. 6B).  Previous reports have 
shown that antigen-specific bovine CD4 T cells can also be divided by their expression of CD27 
and CD45R (25).  To confirm these previous results and to validate our results of our γδ T cell 
analysis, we examined parallel cultures to determine the distribution of effector/memory CD4 
subsets responding to M. bovis infection.  As seen in Figure 5C, after 6 days, the CD4 TCM subset 
exhibited the highest proliferative capacity following in vitro restimulation with mycobacterial 
antigens compared to non-responding CD4 T cells.  Our results suggest that the TCM subset 
comprises the majority of the in vitro proliferative response to mycobacterium antigens for both 
γδ and CD4 T cells.  
 
Increased expression of CD27 on bovine peripheral γδ T cells correlates with memory-type 
responses 
TCM cells are highly proliferative, abundant in lymph nodes, and retain their expression of 
the homing receptors CCR7 and CD62L (33). The results described in Fig. 6 suggest that 
peripheral M. bovis-specific γδ T cells share functional similarities (i.e. high proliferative capacity) 
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with central memory T cells (16).  To address this hypothesis, we evaluated the expression of 
CD62L on peripheral M. bovis-specific γδ T cells. As seen in Fig 6, following a 6-day stimulation 
with PPD-b, CD27+ M. bovis-responsive γδ T cells co-expressed CD62L compared to γδ T cells 
that did not proliferate to M. bovis antigens.  In contrast, M. bovis-specific CD27+ CD4 T cells 
were low for CD62L expression compared to non-M. bovis-specific CD4 cells.  These data are 
consistent with previous descriptions identifying the majority of M. bovis-specific CD4 T cells in 
the peripheral blood as TEM cells (Fig. 7) (25). Therefore, similar to human γδ T cells, M. bovis-
responsive bovine γδ T cells display phenotypic and functional properties of TCM memory cells 
(25, 33). 
 
Bovine M. bovis-specific γδ T cells upregulate expression of the tissue-associated chemokine 
receptors CXCR3 and CCR5 
Chemokine receptor expression is modulated during differentiation of both CD4 and γδ T 
cells (15, 33, 34).  We hypothesized that antigen responsive γδ T cells would modify the expression 
of certain homing receptors that would allow cells to migrate to tissues and sites of inflammation.  
PBMCs from infected cattle were stimulated with PPD-b, as described above. As seen in Fig. 8A 
and 8B, M. bovis-responsive bovine γδ T cells express higher surface levels of both CCR5 
(RANTES/macrophage inflammatory protein-1α/-1β receptor) and CXCR3 compared to non-
responding γδ T cells.  As seen in Fig. 8C, antigen-specific CD4 T cells also express higher levels 
of CCR5 and CXCR3 compared to nonresponsive CD4 T cells.  The increased expression of CCR5 
and CXCR3 on M. bovis-responsive CD4 and γδ T cells is expected to enable these populations to 




Figure 2 Proliferative responses in response to in vitro stimulation with mycobacterial 
antigens. 
PBMCs from uninfected (n= 6) or virulent M. bovis–infected animals (n= 10) were labeled with 
CellTrace, and 5 × 106 cells/ml were cultured for 6 days in the presence or absence of 200 UI/ml 
PPD-b or 2 μg/ml ESAT-6/CFP-10. Cells were labeled with anti-bovine γδ TCR or CD4 and 
analyzed by flow cytometry for CellTrace dilution. Representative histograms of proliferative 
responses from a M. bovis-infected and control animal, gated on total live cells, lymphocytes (SSC-
A vs FSC-A), and cells expressing the γδ TCR (A) or CD4 (B) Percentage of γδ T cells (C) and 
CD4 T cells (D) from M. bovis infected and uninfected animals that proliferated in response to 
mycobacterial antigens, as measured by CellTrace dilution, at 4-, 8- or 12-weeks post aerosol 
challenge. Analysis was performed with Flowjo software. Background proliferation was 
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Figure 3. Evaluation of CD45RO and CD45R expression on M. bovis-specific γδ and CD4 T 
cells. 
Approximately 8 weeks after aerosol challenge with M. bovis, PBMCs from M. bovis–infected 
animals (n= 10) were labeled with CellTrace, and 5×106 cells/ml were cultured for 6 days in the 
presence or absence of PPD-b.  Cells were labeled with anti-bovine CD4, or γδ TCR; and CD45RO 
or CD45R expression by flow cytometry within proliferative subsets as determined by CellTrace 
dilution. (A) Gating hierarchy (gating sequence as depicted by the arrows): lymphocytes (gate 1), 
live cells (gate 2), γδ or CD4 T cells (gate 3), proliferating (1) and non-proliferating cells (2) and 
CD45RO or CD45R expression (gate 5). (B and C) The expression of CD45RO or CD45R was 
determined for individual T cell subsets CD4 T cells (B) or γδ T cells (C) or based on CellTrace 
staining intensity (i.e., bright or dim). Data are presented as means (± SEM). p values for 
differences from responding and non-responding fractions for the respective T cell subset (i.e., 
comparisons between black and grey bars for each graph) were as follows: *, p < 0.05; **, p < 
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Figure 4. CD27 expression on bovine γδ and CD4 T cells ex vivo and in response to mitogen. 
Using flow cytometry, bovine PBMCs from healthy cows were analyzed for CD4 or γδ TCR 
expression.  Gating hierarchy (gating sequence as depicted by the arrows): live cells (gate 1), 
lymphocytes (gate 2), γδ or CD4 T cells (gate 3).  Each lymphocyte population was further 
analyzed for CD27 expression following mock or PWM stimulation for 6 days (dot-plots). Data 








































                                    
Figure 5. CD27+ expression correlates with robust antigen-specific responses to M. bovis. 
 Approximately 8 weeks after virulent M. bovis infection, PBMCs (5×106 cells/ml) were labeled 
with CellTrace violet and restimulated in vitro for 6 days in the presence or absence of PPD-b, 
ESAT-6/CFP-10 or left unstimulated. Cells were then labeled with anti-bovine CD4 or γδ TCR, 
and CD27. CellTrace dilution (proliferative responses) and CD27 cell surface expression was 
determined for (A) γδ T cells and (B) CD4 T cells. Data are presented as means ± SEM; n = 10. p 
values indicate differences between CellTrace dim and positive fractions for the respective T cell 
subset (i.e., comparisons between black and grey bars for each graph) as follows: *, p < 0.05; **, 








































































                          
Figure 6. Phenotype of TCM, TEM and effector γδ and CD4 T cells proliferating in response 
to M. bovis. 
PBMCs were isolated from calves ~ 8 weeks after challenge with virulent M. bovis. Cells were 
stained with CellTrace dye and incubated with M. bovis PPD-b for 6 days. A flow cytometric-
based proliferation assay was used to study CD45R and CD27 expression on M. bovis-specific 
CD4 and γδ T cells. (A) Stimulated PBMCs were analyzed for proliferative responses. Live CD4 
and γδ T cells were gated based on response to M. bovis (i.e., proliferating cells) and analyzed for 
CD27 versus CD45R expression within CellTrace bright (i.e., non-proliferative fraction; black 
bars) or CellTrace dim (i.e., proliferative fraction; grey bars) fractions. (B and C) Relative 
contribution of γδ and CD4 T cells to proliferative response to PPD-b within CD45R/CD27 
defined cell populations (CD45R+CD27+; CD45R-CD27+; CD45R-CD27-; CD45R+CD27-). 
Data are presented as mean (± SEM) (n = 10). *, p < 0.05; **, p < 0.01, p ***<0.001, p****<0.0001 
as determined by Student’s t test.  
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Figure 7. Memory marker expression of CD27 and CD62L T cell subsets of M. bovis-infected 
cattle. 
PBMCs were isolated from calves ~ 8 weeks after challenge with virulent M. bovis. Cells were 
stained with CellTrace dye and incubated with M. bovis PPD-b for 6 days. Flow cytometry was 
used to study both CD27 and CD62L expression on M. bovis-specific T cells. Live lymphocytes, 
CD4 or γδ T cells were gated based on responsiveness to M. bovis (i.e., proliferating cells) and 
analyzed for CD27 versus CD62L expression. (A) Representative dot plots from an M. bovis 
infected animal, gated on dividing and nondividing (non-specific) CD4 or γδ T cells. Data are 
presented as CD27 versus CD62L expression. Cumulative data depicting the frequencies of CD27 
and CD62L expressing γδ T cell subsets (B) and CD4 T cell subsets (C) by dividing (dark bars) 
and nondividing (grey) cells are shown for all infected animals. Data are presented as mean (± 
SEM) (n = 10). *, p < 0.05; **, p < 0.01, p ***<0.001, p****<0.0001 as determined by ANOVA.   
































































Figure 8. Surface expression of chemokine receptors on M. bovis-specific peripheral γδ and 
CD4 T cells. 
PBMCs were isolated from calves ~ 8 weeks after challenge with virulent M. bovis. Cells were 
stained with CellTrace dye and incubated with PPD-b for 6 days. Flow cytometry was used to 
study CXCR3 and CCR5 expression on M. bovis-specific CD4 and γδ T cells. Cells were surface 
stained and then analyzed by flow cytometry for CXCR3 and CCR5 expression. (A) 
Representative histograms of CXCR3 and CCR5 expression on antigen-responsive (blue solid 
line) and non-responsive CD4 and γδ T cells (red solid line). Cumulative results from live γδ (B) 
and CD4 T cells (C), gated based on response to M. bovis (i.e., proliferating cells) and analyzed 
for CXCR3 or CRR5 expression. The FMO control is shown in grey shaded histograms. Data are 
presented as mean ± SEM MFI expression of cell surface markers. *, p < 0.05; **, p < 0.01, p 
***<0.001 indicates a significant difference (p< 0.05) from antigen-responsive cells compared to 


























































Following M. bovis infection, a marked in vitro expansion suggests that bovine γδ T cells 
can mount memory-like responses upon restimulation with mycobacterial antigen (Fig. 1) and 
[reviewed (35)]. However, to date, a combination of surface markers that effectively identify 
effector/memory-like subsets of bovine antigen-specific γδ T cells have not been reported.  Here, 
we show that compared to CD4 T cells, proliferating M. bovis-specific γδ T cells do not 
significantly alter CD45RO expression after restimulation with mycobacterial antigens in vitro.  
Our results agree with reports showing that γδ T cells from human TB patients do not modulate 
CD45RO expression compared to γδ T cells from non-infected subjects (16, 17).  Thus, γδ T cells 
may acquire a ‘pre-activated’ state early in their development and thus, CD45RO is not useful to 
identify antigen-experienced γδ T cells.  In contrast to CD45RO expression, we found that 
proliferating γδ T cells from M. bovis infected cattle, downregulated the expression of CD45R 
following antigen restimulation in vitro compared to non-responsive γδ T cells (Fig. 2) (28, 36). 
These observations indicate that mycobacteria-specific γδ T cells that can be identified using 
CD45R. 
In humans, two subsets of γδ T cells develop in response to antigen stimulation and are 
identified based upon their expression of CD27 (22).  These subsets exhibit unique functions 
during mycobacterial infection that parallel the functions attributed to differentiated subsets of 
CD8 and CD4 T cells (15, 29). Moreover, flow-cytometric analysis of CD27 expression on 
circulating MTB-specific T cells can help to discriminate disease progression (30).  Thus, 
assessing the changes in γδ T cell effector/memory phenotype based on CD27 might be helpful to 
monitor changes related to TB disease progress and vaccine-induce protection as previously 
reported (16, 18).  Although the expression of CD27 in bovine cells has been reported before, its 
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expression on bovine γδ and CD4 T cells has not been determined (31).  We observed that in 
healthy adult cattle ~70% of CD4 T cells, and ~50% of γδ T cells express CD27.  Importantly, we 
observed that a subpopulation of γδ +CD27+ effector/memory-like T cells from M. bovis infected 
cattle develop in response to Ag stimulation and exhibit high proliferative capacity after 
restimulation with either PPD-b or the M. bovis protein antigen, ESAT-6/CFP-10.  Our 
observations are consistent with findings in humans, where patients with acute pulmonary TB, and 
BCG vaccinated individuals, demonstrate increases in circulating CD27+ Vγ9Vδ2+ T cells, and 
these cells exhibit enhanced proliferative activity upon stimulation with mycobacterial antigens 
(16, 37).  Thus, our results suggest that CD27 expression may be potentially used to monitor γδ T 
cell responses to M. bovis infection in cattle.  
Coexpression of cell surface markers CD45RA and CD27 has been used to functional 
segregate subsets of human and non-human primate γδ T cells (15, 16).  In non-human primates, 
TEM (CD45RA- CD27+) Vγ9Vδ2 T cells expansion after a secondary M. tb challenge correlates 
with protection against fatal TB (17-19).  Interestingly, there is a significant reduction in effector 
γδ cells (CD27- TEM and TEMRA  cells) in patients with active infection, but the population rebounds 
after successful clinical treatment (38).  Our data show that M. bovis-specific γδ T cells can be 
divided into four distinct subsets: naïve (CD27+CD45R+), TCM (CD27+CD45R-), TEM (CD27-
CD45R-), TEMRA (CD27-CD45R+).  Consistent with reports from humans, our data show that 
virulent M. bovis infection is associated with an expansion in primarily the γδ TCM subset in the 
blood (Fig. 5) (39).  Although effector functions were not assessed in this study, it has been shown 
that γδ T effectors develop functional defects and progressively lose the ability to produce IFNg 
compared with γδ T cells from healthy tuberculin positive adults (40).  Whether the loss of γδ T 
cell effectors impacts the ability to acquire memory T cell properties is not known. Together, our 
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observations, coupled with reports from human TB patients, demonstrate a negative correlation 
between γδ T effector (CD27- CD45R-) phenotype and disease.  Further studies should address the 
functional implications of these phenotypic changes following M. bovis experimental challenge 
and vaccine efficacy studies in the bovine. 
Lastly, we show that M. bovis-specific bovine γδ T cells exhibited higher CCR5 and 
CXCR3 compared to non-responding γδ T cells.  Similarly, a higher expression of CXCR3 and 
CCR5 is preferentially found on circulating γδ T cells from TB patients (38, 41).  The expression 
of CCR5 and CXCR3 on M. bovis-specific γδ and CD4 T cells suggests that these cell populations 
are memory/effector T cells (15, 38, 41).  Similar to our results, Blumerman et al. showed that 
bovine γδ T cells participating in recall responses against Leptospira antigens exhibited increased 
transcription of CCR5 and CXCR3 (42).  γδ T cells are amongst the first cells to localize to the 
granuloma following M. bovis infection (43).  The increased expression of CCR5 and CXCR3 on 
M. bovis-responsive γδ T cells presumably enables this population to migrate into the inflamed 
peripheral tissue.  We did not investigate the functionality of CCR5 and CXCR3 on this population, 
however studies in human γδ T cells have confirmed their capacity to migrate towards the 
inflammatory chemokines RANTES and IP-10 (38).  Importantly, the chemokine receptor profile 
of peripheral γδ T cells may differ from that of γδ T cells at the site of infection; thus, further 
studies will address the functionality of CXCR3 and CCR5 in bovine γδ T cells, and the expression 
of tissue homing receptors such as CXCR3 and CCR5 on cells within granuloma lesions of M. 
bovis-infected cattle.   
In conclusion, our results show that, like humans, γδ T cells from M. bovis-infected cattle 
can be divided into phenotypic and functional subsets based upon their surface expression of 
CD27, CD45R, and the homing molecules, CXCR3 and CCR5.  Further elucidation of the pathway 
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of γδ T cell differentiation and the functional implications will contribute significantly to our 
ability to engage the γδ T cell response in effective immune responses to mycobacterial diseases 
of both humans and animals. 
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 ABSTRACT 
The Mycobacterium bovis Bacillus Calmette-Guerin (BCG) vaccine is administered 
parenterally to infants and young children to prevent tuberculosis (TB) infection. However, the 
protection induced by BCG is highly variable and the vaccine does not prevent pulmonary TB, the 
most common form of the illness. Until improved TB vaccines are available, it is crucial to use 
BCG in a manner which ensures optimal vaccine performance. Immunization directly to the 
respiratory mucosa has been shown to promote greater protection from TB in animal models. γδ T 
cells play a major role in host defense at mucosal sites and are known to respond robustly to 
mycobacterial infection. Their positioning in the respiratory mucosa ensures their engagement in 
the response to aerosolized TB vaccination. However, our understanding of the effect of 
respiratory BCG vaccination on γδ T cell responses in the lung is unknown. In this study, we used 
a calf model to investigate the immunogenicity, and phenotypic profile of peripheral and mucosal 
γδ T cells responding to aerosol BCG vaccination. We observed robust mucosal and systemic M. 
bovis-specific IFN-γ and IL-17 production by both γδ and CD4 T cells. Importantly, BCG 
vaccination induced effector and memory cell differentiation of γδ T cells in both the airways and 
peripheral blood, with accumulation of a large proportion of effector memory γδ T cells in both 
compartments. Our results demonstrate the potential of the neonatal calf model to evaluate the 
2 
safety and immunogenicity of TB vaccine candidates that are to be administered via the respiratory 
tract and suggest that aerosol immunization is a promising strategy for engaging γδ T cells in 




Mycobacterium bovis is a member of the M. tb complex and is the causative agent of bovine 
TB (bTB) and zoonotic TB infection (1).  The attenuated M. bovis vaccine strain, Bacille Calmette-
Guerin (BCG), is the only vaccine that is currently available to prevent TB infection in humans.  
It is approved for intradermal use and is commonly administered at birth to infants in TB endemic 
areas.  The BCG vaccine has been tested experimentally in cattle, and like humans, the protection 
induced by parenteral BCG vaccination is transient and highly variable [reviewed (2)].  Although 
parenteral BCG vaccination is not efficacious against pulmonary TB, no other vaccine has shown 
improved efficacy over BCG, and it remains the ‘gold-standard’ by which all other TB vaccines 
are compared in both humans and cattle.  Furthermore, BCG has well-recognized health benefits 
in human infants and is likely to be continued to be administered to populations in developing 
countries [reviewed in (3)].  Therefore, until improved TB vaccines are available, it is crucial to 
use BCG in a manner which ensures optimal vaccine performance.   
Immunization directly to the respiratory mucosa with BCG, attenuated M. tb and vectored 
vaccines has been shown to promote greater protection from TB in rodents and non-human 
primates (4-10).  A single intranasal vaccination with a recombinant human type 5 adenovirus 
expressing antigen 85A (AdHu5Ag85A) offered superior protection to subcutaneous BCG 
vaccination alone (11).  In BCG-vaccinated cattle, boosting via the respiratory mucosa with 
AdAg85A induced local mucosal and systemic responses that were similar in magnitude to 
intradermal boosting (12).  The vaccine-induced protection seen after immunization via the 
respiratory tract is believed to be associated with the preferential recruitment of antigen-specific 
CD4 T cells to the lung airways (5, 13-18), which allows for an immediate response upon pathogen 
exposure, preventing bacilli from establishing infection (19-21).  While it is clear that IFNg-
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secreting CD4 T cells are an essential component for protection against TB, IFNg secretion is a 
poor correlate of protection (22, 23).  The activity of other lymphocyte populations, notably γδ T 
cells, may represent another major essential component for protection or resistance to TB 
[reviewed (24)].   
γδ T cells play a major role in defense against pathogens, especially at mucosal sites such 
as the lower respiratory tract (25-28).  Although γδ T cells fall into the innate-like category, 
adaptive features have also been reported in multiple studies [reviewed (29, 30)].  Humans 
vaccinated with BCG have a population of γδ T cells that expands robustly in response to in vitro 
restimulation with mycobacteria antigens (31).  In non-human primates, administration of 
phosphoantigens/IL-2 induced a marked expansion and pulmonary accumulation of 
phosphoantigen-specific Vγ2Vδ2 T cells, significantly reducing M. tb burdens and associated lung 
pathology (9, 32).   
Like CD4 T cells, γδ T cells have the capacity to differentiate into subsets that differ in 
their migratory and functional properties.  In humans, γδ T cell subsets are divided according to 
the surface expression of CD45RA and CD27.  Naïve CD45RA+ CD27+ cells represent ~10-20% 
of the γδ T cells circulating population in healthy adults.  Central memory (TCM) cells CD45RA− 
CD27+ are more plentiful in the blood and exhibit robust proliferative capacity, but limited effector 
functions (33).  Effector memory (TEM) and CD45RA+ CD27- (TEMRA) γδ T cells are generally 
recognized to be fully differentiated subsets and express receptors for homing to inflamed tissues, 
display immediate effector functions and are highly prevalent in sites of inflammation (34).  
Consistent with their differential homing capacity, certain chemokine receptors are also useful for 
classifying functional γδ T cell subsets (35).  The expression of the homing receptors CXCR3, 
CCR5 and CD62L have been used to differentiate effector and memory γδ T cells subsets (36, 37).   
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Effector T cells expand during active disease, whereas memory cells correlate with reduced 
mycobacterial burden and associated pathology following experimental infection (38, 39).  
Interestingly, serious TB disease results in reduced γδ T cell effector functions in the periphery 
(33, 34).  Consistent with this observation, there is a progressive loss of CD27neg TEM and TEMRA 
γδ T cell subsets from the peripheral blood of patients with active TB (34, 40).  We have recently 
shown that virulent M. bovis infection results in differentiation of circulating bovine γδ T cells to 
a TCM phenotype similar to that described in humans (Guerra-Maupome et al., manuscript under 
review).  However, little is known regarding the response by lung-associated γδ T cells during 
Mycobacterial infection and vaccination (41, 42), and there are limitations for assessing the 
biological significance of γδ T cells in the response to TB in humans.   
As a natural host of TB infection, cattle represent a highly relevant animal model to 
investigate the immune response of γδ T cells to Mycobacterium vaccination and infection (2, 
43, 44).  Furthermore, respiratory BCG vaccination is an established, well-characterized 
experimental system that is particularly useful for studying the development of TB-specific 
immune responses in the lungs.  To this end, calves were vaccinated with BCG via the 
respiratory tract, and vaccine immunogenicity, and the differentiation of responding M. bovis-
specific γδ T cells was examined in the peripheral blood and lower respiratory tract.  We 
hypothesized that vaccination with BCG via the respiratory tract would result in the development 
of robust immune responses and phenotypic changes in mucosal and circulating γδ T cell 
populations.  Improved characterization of γδ T cell phenotype and function during 
mycobacterial infection and vaccination will contribute to the development of improved 
strategies for harnessing their response in protection against TB.   
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 MATERIALS AND METHODS  
Animal Use Ethics  
All animal procedures were conducted in strict accordance with federal and institutional 
guidelines and were approved by the Kansas State University Institutional Animal Care and Use 
Committee (Protocol Number: 27–2956).  A total of 28 Holstein steers (~6-8-week-old) were used 
in the following experiments.  Animals were housed in outdoor pens at the College of Veterinary 
Medicine, Kansas State University in Manhattan, KS.  Animals had ab libitum access to hay, water, 
and concentrate.  Steps were taken to avoid prolonged restraint and discomfort during all handling 
procedures.  Body temperature was assessed if animal demonstrated signs of clinical illness and 
antibiotics and analgesics were administered as needed if animals presented with clinical disease 
independent of the experimental protocol.  At the end of the study animals were humanely 
euthanized by barbiturate overdose.  The calves showed no clinical signs following administration 
of the vaccine, and we observed no pathological changes in the lungs or tissues of the upper 
respiratory tract.  
 
Mycobacterium bovis BCG aerosol vaccine procedures 
M. bovis BCG Danish strain was a gift from Dr. Ray Waters at the National Animal Disease 
Center, USDA.  BCG was prepared using standard techniques in Middlebrook 7H9 liquid media 
(Becton Dickinson, Franklin Lakes, NJ) supplemented with 10% oleic acid-albumin-dextrose 
complex (OADC) plus 0.05% Tween 80 (Sigma, St. Louis, Missouri).  For the first experiment, 
treatment groups consisted of non-infected steers (n = 3) and animals receiving 1 x 108 colony-
forming units (CFU) of M. bovis BCG Danish strain (n = 11).  For the second study, treatment 
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groups consisted of non-infected calves (n = 7) and animals receiving 1 x 108 CFU of M. bovis 
BCG Danish strain (n = 7).  For both studies, BCG inoculum was delivered to restrained calves by 
aerosol as described by Palmer et al. (45).  Briefly, inoculum was nebulized into a mask (Trudell 
Medical International, London, ON, Canada) covering the nostrils and mouth, allowing regular 
breathing and delivery of the bacterial inoculum to the upper and lower respiratory tract via the 
nostrils.  Clinical signs, including cough, dyspnea, and loss of appetite were monitored daily 
throughout the study.  No clinical signs or pathology associated with BCG immunization were 
observed. 
 
PBMC Isolation  
Peripheral blood was drawn from the jugular vein into 2 × acid-citrate-dextrose solution. 
For peripheral blood mononuclear cells (PBMC) isolation, blood was diluted 1:1 in phosphate-
buffered saline (PBS), cells were collected from buffy coat fractions, and PBMCs were isolated 
by density centrifugation on Histopaque (Sigma).  Contaminating red blood cells were removed 
using RBC lysis buffer.  Finally, cells were washed three times, counted in an hemocytometer and 
resuspended in complete RPMI (cRPMI) composed of RPMI-1640 (Gibco, Carlsbad, CA) 
supplemented with 2 mM L-glutamine, 25 mM HEPES buffer, 1% antibiotic-antimycotic solution, 
1% non-essential amino acids 2% essential amino acids, 1% sodium pyruvate, 50 μM 2-
mercaptoethanol (all from Sigma, St. Louis, MO), and 10% (v/v) heat-inactivated fetal bovine sera 
(FBS). 
 
Bronchoalveolar Lavage Fluid Collection and cell Isolation  
8 
Broncheoalveolar lavage (BAL) samples were collected using a modified stallion urinary 
catheter (JorVet, Jorgensen Laboratories). The catheter was blindly passed through the nose and 
advanced through the trachea until lodging in the bronchus.  A total of 180 mL of sterile saline 
was divided into three aliquots.  An aliquot was first introduced to the lower respiratory tract, 
followed by immediate suction to obtain lower airway washes.  The procedure was repeated twice 
more.  All three aliquots were pooled at the end of the procedure.  BAL samples were kept on ice, 
filtered over sterile gauze, and centrifuged at 200 x g for 10 minutes at 4°C.  Contaminating red 
blood cells were removed using RBC lysis buffer.  Cells were washed, resuspended in cRPMI, 
counted and 1 x 106 cells/well were resuspended in cRPMI and plated in 96 well plates. BAL cells 
were stimulated as described above.  Plates were incubated for 72 hours for cytokine measurement 
at 37° C, 5% CO2 incubator.  
 
Tissue collection and cell suspension  
All calves were euthanized 16 weeks after vaccination by intravenous administration of 
barbiturate overdose.  Tissues were examined for gross lesions.  Mediastinal and tracheobronchial 
lymph node tissues were collected and placed in cold cRPMI.  Cells from lymph nodes were gained 
by sieving small pieces of tissue through steel meshes.  Contaminating red blood cells were 
removed using RBC lysis buffer.  Finally, cells were washed three times, counted in a 
hemocytometer and resuspended in cRPMI.  Subsequently, cells (5 x 105 /well) were plated in 
round-bottom 96-well plate in duplicates, cultured for 6-days at 37°C, in the presence of 5% CO2, 
and stimulated with M. bovis PPD (PPD-b, 200 IU/mL, Prionics Ag, Sclieren, Switzerland), 
recombinant (r)Ag85A (1 μg/ml, LIONEX Diagnostics and Therapeutics GmbH, Braunschweig, 
Germany) and rTB10.4 (1 μg/ml, LIONEX Diagnostics and Therapeutics GmbH).  Concanavalin 
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A mitogen (ConA, 5 µg/ml, Sigma) or cRPMI medium were used as positive and negative control, 
respectively.   
 
Long-term cell culture 
Following PBMC isolation, long-term cell culture was performed as described by Maggioli 
et al. (39, 46).  Briefly, PBMC were cultured (2 × 106 cells/well) in 24 well flat-bottom microtiter 
plates (Nunc, Thermo Fisher, Waltham, MA) and stimulated with a cocktail of M. bovis PPD 
(PPD-b, 200 IU/ml, Prionics Ag, Sclieren, Switzerland), rTB10.4 and rAg85A (1 μg/ml each) in 
cRPMI medium for 12 days 37°C, 5% CO2.  Media containing human rIL-2 (Sigma, 10 IU/ml) 
was used to replace media from the PBMC cultures at days 3 and 7.  Fresh media without IL-2 
was used at days 10 and 12.  At day 13, autologous APCs were isolated by adherence incubating 
2 × 105/well of freshly isolated PBMC in complete medium at 37°C, 5% CO2 for 90 min in 96-
well ELISPOT plates (Millipore, Watford, UK) previously coated overnight with anti-bovine IFNγ 
capture-mAb (Kingfisher) and blocked in cRPMI, for 2 h at 37°C, 5% CO2.  Non-adherent cells 
were discarded, and the adherent cells washed twice times with warm cRPMI.  Long-term cell 
cultures and antigen were added (2 × 104 /well) to the ELISPOT plate and incubated for 20 h at 
37°C, 5% CO2 in the presence of autologous APC.  
 
Ex vivo and Long-term ELISPOT 
The IFNγ and IL-17A ELISPOT assay was performed as described by Maggioli et al. (39, 
46).  Briefly, 96-well ELISPOT plates (Millipore) were coated at 4°C overnight with an anti-
bovine IFNγ capture mAb or IL-17A capture mAb (both from Kingfisher Biotech, Inc., St. Paul, 
MN), followed by a blocking step in cRPMI, for 2 h at 37°C, 5% CO2.  Fresh isolated PBMC or 
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long-term cultured cells (2 × 104/well) were added to ELISPOT plates and stimulated with either 
PPD-b (5 μg/ml), rTB10.4 and rAg85A (1 μg/ml each), ConA (5 µg/ml) or medium alone.  Plates 
were incubated 20 h (IFNγ) or 48 h (IL-17A) at 37°C, 5% CO2.  Spot forming cells (SFC) were 




PBMC were labeled using CellTrace Violet (Invitrogen, Carlsbad, CA) prior to cell culture 
following manufacturer’s instructions.  Briefly, freshy isolated PBMCs were resuspended at 1 × 
107 cells/mL in PBS containing 10 μM/ml of the CellTrace dye.  After gently mixing, PBMCs 
were incubated for 20 min at 37°C in a water-bath.  Labeling was quenched by using an equal 
volume of FBS, and cells were washed three times with RPMI medium.  Subsequently, cells (5 x 
105 /well) were plated in round-bottom 96-well plate in duplicates, cultured for 6-days at 37°C, 
5% CO2, in the presence of M. bovis PPD (PPD-b, 200 IU/mL).  ConA (5 µg/ml) or cRPMI 
medium were used as positive and negative control, respectively.  After six days, cells were surface 
stained (see Flow cytometry section) and analyzed for proliferation and surface marker expression 
by flow cytometry.  
 
Flow Cytometry  
Following the appropriate culture duration, cells were stained with primary and secondary 
monoclonal antibodies (mAbs) listed on Table 2.  All incubation steps for staining were performed 
in FACS buffer (PBS with 10% FBS and 0.02% NA-azide) and incubated for 25 min at 4°C.  Cells 
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were washed and fixed with BD FACS lysis buffer (BD Biosciences, Mountain View, CA) for 10 
min at room temperature, washed and resuspended in FACS buffer until analysis.   
For intracellular staining, 1 x 106 cells were incubated in cRPMI containing antigen for 16 
h at 37°C, 5% CO2 with Brefeldin A (GolgiPlug; BD Pharmingen, 10 μg/ml) added at 4 h of 
culture.  After staining cell-surface markers, cells were permeabilized for 30 min using BD 
CytoFix/CytoPerm solution (BD Biosciences) and incubated with IFNγ (Table 2) for 45 min.  
Non-stimulated samples served as negative controls.  Samples were acquired using a BD LSRII 
Fortessa flow cytometer (BD Biosciences).  Data were analyzed using Flowjo software (Tree Star 
Inc., San Carlos, CA).  Lymphocytes were identified in PBMC and BAL samples as shown in 








Secondary Antibody/ Source  Specificity/ Source 
ILA11a APC, Life Technologies Bovine CD4, Washington State University  
GB21a APC-Cy7, Southern Biotech Bovine TCR1 delta chain, Washington State 
University  
GC6a PE-Cy7, Life Technologies Bovine CD45R, Washington State University  
M-T271 AF488, Life Technologies Human CD27, Biolegend 
G025H7 Not applicable Human CXCR3 FITC, Biolegend 
HM-CCR5 Not applicable Human CCR5 Percpcy5.5, Biolegend 
CC302 Not applicable Bovine IFN-γ PE, Serotec  
Cell Trace 
Violet 
Not applicable Not applicable, Life Technologies 
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ELISA 
PBMC and BAL cells were stimulated in vitro as described above.  Plates were incubated 
for 6 days (PBMC) or 72 hours (BAL) at 37° C, 5% CO2 incubator.  Cell culture supernatants were 
stored at -80°C until ELISA analysis.  The concentration of cytokines in cell culture supernatants 
was determined using bovine commercial ELISA kits for IFNg, and IL-17A (all from Kingfisher) 
according to manufacturer’s instructions.  Each sample assayed was measured in duplicate.  
 
Statistical Analyses 
 Results are expressed as averages ± standard errors of the mean (SEM).  Statistical 
significance was determined by one-way Analysis of Variance (ANOVA) followed by Bonferroni 






Aerosol BCG vaccination induced robust mucosal and systemic cellular immune responses 
One of the primary objectives of this study was to determine if a vaccine delivered by 
aerosol to the respiratory tract of calves was safe and immunogenic.  To this end, calves were 
vaccinated via aerosol inoculation with BCG. Control calves remained unvaccinated.  PBMC were 
isolated at 4, 8, 12- and 16-weeks post vaccination (Fig. 9A).  Cells were restimulated in vitro as 
described in Materials & Methods.  IFNγ (upper panels) and IL-17A (lower panels) 
concentrations were analyzed in cell culture supernatants by sandwich ELISA.  Calves were 
monitored twice daily, and we observed no clinical signs in the calves following administration of 
the vaccine, suggesting that this is a safe vaccination approach in immunocompetent individuals. 
Aerosol immunization was also highly immunogenic and elicited potent M. bovis-specific immune 
responses in peripheral blood, as indicate by the robust IL-17A and IFNγ secretion by Ag-
stimulated PBMC.  The response was significantly increased over PBMC from unvaccinated 
controls throughout the 16-week study (Fig. 9A).  
Vaccine-induced responses in the respiratory mucosa were measured from BAL 
mononuclear cells at 4-, 12- and 16-weeks post vaccination (Fig. 9B). BAL cells from BCG 
vaccinated calves produced significant quantities of IL-17A and IFNγ in recall response to 
mycobacterial antigens, while BAL cells from unvaccinated animals did not (Fig. 9B). 
Vaccine-induced cellular immune responses were also evaluated in lung-draining lymph 
nodes during necropsy, 16 weeks after vaccination (Fig. 10).  Single cell suspensions were 
prepared from the mediastinal and tracheobronchial LN, and in vitro antigen stimulation assays 
were performed as described in Materials & Methods.  Cell culture supernatants were analyzed by 
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sandwich ELISA for IFNγ (upper panels) and IL-17A (lower panels).  Similar to the results from 
the BAL, cells isolated from the tracheobronchial (Fig. 10A) and mediastinal LNs (Fig. 10B) of 
BCG-vaccinated calves secreted IFNγ and IL-17A in specific response to in vitro PPD-b 
restimulation and the response was significantly increased over samples from unvaccinated 
controls at 16 week’s post vaccination.   
 
Mucosal BCG vaccination elicits effector and central memory T cell responses  
Ex vivo assays are considered a measure of effector and effector memory T cell responses.  
While most protective TB vaccines elicit ex vivo IFNγ responses, not all vaccines that induce this 
response provide protection (2).  Long-term cultured IFNγ ELISPOT responses to TB vaccination 
negatively correlate with mycobacterial burden and TB-associated pathology and positively 
correlate with vaccine-induced protection (47-50).  In cattle and humans, the long-term cultured 
IFNγ ELISPOT assay evaluates central memory T cell responses following TB infection and 
vaccination (38, 39).  Here, we determined if aerosol BCG vaccination was capable of eliciting 
both ex vivo and long-term cultured responses, as has been previously reported for other protective 
TB vaccines (39, 47, 48).   
PBMC were isolated and short term stimulations were performed to quantify the numbers 
of ex vivo effector IFNγ and IL-17A-secreting cells (spot-forming cells, SFC) by ELISPOT assays 
(39, 46).  Aerosol BCG vaccination elicited significant numbers of effector PPD-b and 
rTb10.4/Ag85a-specific T cells in the peripheral blood (Fig. 11A).  Long-term cultures were 
performed to quantify the numbers of M. bovis-specific central memory T cells in peripheral blood. 
As seen in Fig. 11B, aerosol BCG vaccination elicited significant numbers of IFNγ-producing 
central memory T cells.  Antigen-specific responses to rTb10.4/Ag85a and PPD-b both exceeded 
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the long-term ELISPOT responses measured from non-vaccinates (Fig. 11B).  Thus, aerosol BCG 
vaccination of elicits strong recall effector and central memory responses in calves (51, 52).  
 
Aerosol BCG vaccination induces a robust systemic and mucosal antigen-specific γδ T cell 
responses  
Having demonstrated that BCG vaccination via the respiratory tract elicited effector and 
memory T cell responses in the calf, we next investigated the differentiation status of the 
responding γδ T cell populations.  Using flow cytometry, we assessed mycobacterial-specific γδ T 
cell responses in the peripheral and mucosal compartment. It is well established that aerosol BCG 
vaccination induces effector and memory CD4 T cell differentiation (53); therefore, where 
relevant, we made comparisons to the M. bovis-specific CD4 T cell populations in the same 
animals.   
Following 4-, 8-, 12- and 16-weeks post vaccination, PBMC were isolated, labeled with 
CellTrace dye and cultured for 6 days in the presence or absence of PPD-b.  On day 6 of culture, 
cells were analyzed by flow cytometry for T cells that divided in response to mycobacterial antigen 
restimulation.  Representative γδ and CD4 T cell flow plots from a vaccinated and control animal 
are depicted in Fig. 12A.  Consistent with the results in Fig. 1-3, aerosol BCG vaccination induced 
long-term, robust systemic cellular responses, and γδ T cells appear to participate in this response, 
as evidenced by the robust proliferative responses that persisted in vaccinated calves through at 
least 16-weeks post vaccination (Fig. 12C).  The observed γδ T cell recall responses were M. bovis-
specific, as cells from non-vaccinated cattle did not respond to the complex or protein 
mycobacterial antigens. Similarly, only CD4 T cells from BCG-vaccinated animals, and not 
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control animals, participated in the recall response to mycobacterial antigen restimulation in vitro 
(Fig. 12B and D). 
The frequency of vaccine-elicited IFNγ-producing γδ T cells was determined by 
intracellular cytokine staining on PBMC and BAL cells after ~8 weeks post vaccination.  Aerosol 
BCG vaccination induced M. bovis-specific, IFNγ-producing γδ T cells in both the peripheral and 
mucosal compartments (Fig. 13A).  The frequency of γδ T cells producing IFNγ in response to 
PPD-b stimulation was significantly higher in animals that were vaccinated with BCG compared 
to unvaccinated controls.  Similarly, aerosol vaccination induced IFN-γ-producing antigen-
specific CD4 T cells in the peripheral and mucosal compartment (Fig. 13B).  Thus, aerosol BCG 
vaccination induces functional, M. bovis-specific γδ T cells in both the mucosal and systemic 
compartment. 
 
M. bovis-specific γδ T cells from BCG vaccinated calves adopt a memory phenotype based 
on CD27 and CD45R expression 
 We have recently shown that virulent M. bovis infection in cattle promotes the 
differentiation of circulating γδ T cells into subsets that share characteristics with human TCM γδ  
T cells (CD45R- CD27+ CD62Lhi) (M. Guerra-Maupome, M. V. Palmer, W. R. Waters, J. L. 
McGill, manuscript under review).  Here, we investigated the phenotype of both systemic and 
lung-associated γδ T cells to determine the impact of aerosol BCG vaccination on γδ T cell 
differentiation.  
In the circulating compartment, aerosol BCG vaccination induced a significant increase in 
γδ T cells with a TCM (CD45R- CD27+) phenotype, and a moderate increase in γδ T cells with a 
TEM (CD45R- CD27-) phenotype (Fig. 14A).  The cumulative proportions of effector/memory γδ 
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T cells from all calves are shown in Fig. 14B.  Our results suggest that BCG vaccination, similar 
to virulent M. bovis infection, elicits a γδ TCM phenotype in the circulation that comprises the 
majority of the M. bovis-specific proliferative response.  Interestingly, however, in contrast to our 
previous studies with virulent M. bovis infection, BCG vaccination also induced the expansion of 
circulating γδ T cells with a TEM (CD45R- CD27+) phenotype. 
In the mucosal compartment, we observed that aerosol BCG vaccination preferentially 
induced the differentiation of γδ TEM (CD45R- CD27+) cells, with low proportions of TCM cells 
compared to the circulating population (Fig. 15A).  The relative contribution of mucosal γδ T cell 
subsets in the response to PPD-b are shown in Fig. 15B.   
Thus, BCG vaccination via the respiratory route induces the differentiation of antigen-
specific γδ T cells with a TCM phenotype in the periphery, and a TEM phenotype in the mucosal 
compartment. 
 
M. bovis-specific γδ T cells modulate expression of the tissue-associated chemokine 
receptors CXCR3 and CCR5 
Expression of the chemokine receptors CXCR3 and CCR5 has been used to differentiate 
effector and memory T cell subsets (35).  We have previously shown that circulating γδ T cells 
modulate their expression of CXCR3 and CCR5 during virulent M. bovis infection (M. Guerra-
Maupome, M. V. Palmer, W. R. Waters, J. L. McGill, manuscript under review).  The increased 
expression of CCR5 and CXCR3 on M. bovis-responsive T cells is expected to enable these 
populations to migrate into the inflamed tissue.  Therefore, we next investigated the effect of 
aerosol BCG vaccination on the acquisition of lung homing receptors by M. bovis responsive γδ T 
cell in peripheral blood and BAL cells.   
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We observed marked differences in the patterns of chemokine receptor expression by M. 
bovis-responsive γδ T cells isolated from mucosal versus peripheral compartments.  The majority 
of mucosal M. bovis-specific γδ T cells recovered from the BAL expressed lower surface levels of 
CXCR3 compared to non-responding γδ T cells (Fig. 16A).  As seen in Fig. 16B, mucosal antigen-
specific CD4 T cells also expressed lower levels of CXCR3 compared to nonresponsive CD4 T 
cells.  Comparison of chemokine receptor expression by mucosal γδ T cells compared with 
circulating M. bovis-specific γδ T cells, revealed significantly higher expression of CXCR3 by 
circulating antigen-specific populations (Fig. 17C).  The expression of CCR5 on both CD4 and γδ 
T cells followed a similar trend, with increased expression by circulating, M. bovis-specific cells 
and reduced by M. bovis-responsive T cells recovered from the airways; however, this change was 
not statistically significant (Supp. Fig 6).  Together our data show that aerosol BCG vaccination 
induces up-regulation of CXCR3 by circulating γδ T cells, which may confer lung homing 
properties under inflammatory conditions and correlate with the observed effector memory 
phenotype (36).  Conversely, analysis of airway, M. bovis-responsive γδ T cells indicates a 
tendency towards downregulation of chemokine receptor expression, perhaps indicating that T 





Figure 9. Cellular immune responses in the airways and peripheral blood of BCG-
vaccinated calves. 
(A) Peripheral blood was collected 4-, 8-, 12- and 16-weeks after vaccination. PBMC were isolated 
and stimulated for 6 days with PPD-b. Control wells remained unstimulated. (B) BAL were 
collected at 4-, 12- and 16-weeks after vaccination. BAL cells were stimulated for 72 hours in vitro 
with PPD-b. Control wells remained unstimulated. Cell culture supernatants were collected from 
BAL and PBMC cultures and analyzed by commercial ELISA kit for IFNγ (upper panel) and IL-
17 (lower panel). Data represent means ± SEM. *p<0.05, **p<0.01 ***p<0.001 as determined by 
Student’s t test.  
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Figure 10. Cellular immune responses in lung-draining lymph nodes of BCG-vaccinated 
calves. 
Lung-draining tracheobronchial (A) and mediastinal lymph nodes (B), were collected from control 
(n=7) or BCG–vaccinated animals (n= 7) during necropsy at 16 weeks after vaccination. Cells 
were isolated as described in Materials & Methods and restimulated for 6 days with PPD-b. Control 
wells remained unstimulated. Cell culture supernatants were collected from cultures and analyzed 
by commercial ELISA kit for IFNγ (upper panel) and IL-17 (lower panel). Data represent means 




























































                 
Figure 11. Long-term cultured and ex vivo IFNγ responses by cattle after M. bovis aerosol 
vaccination. 
Cultured ELISPOT analysis was performed ~8 weeks after BCG aerosol vaccination. (A) For the 
ex vivo response, freshly isolated PBMCs were stimulated with rTb10.4/Ag85a, PPD-b or medium 
alone for 20 h (IFNγ) or for 48 hours (IL-17A). (B) Long-term cultured cells were generated by 
stimulating PBMC with a cocktail of rTB10.4 and rAg85A (1 μg/ml each), and PPD-b (200 IU/ml) 
for 13 days followed by transfer to ELISPOT plates with APCs and the addition of either 
rTb10.4/Ag85a, PPD-b or medium alone. Medium control responses were subtracted from 
antigen-stimulated responses and results are presented as mean spot forming cells (SFC)/106 cells 
(± SEM) for (A) ex vivo conditions or (B) long-term culture *p<0.05 **p<0.01 ***p<0.001 as 
determined by Student’s t test. 
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Figure 12. Systemic M. bovis-specific responses in response to in vitro restimulation with 
mycobacterial antigens. 
PBMCs from control (n= 10) or BCG–vaccinated animals (n= 18) were labeled with CellTrace, 
and 5 × 106 cells/ml were cultured for 6 days in the presence or absence of PPD-b.  Cells were 
labeled with anti-bovine γδ TCR or CD4 (see Table 1) and analyzed by flow cytometry for 
CellTrace dilution.  (A and B) Representative contour plots of proliferative responses to in vitro 
PPD-b stimulation from a control and BCG-vaccinated animal. Gating hierarchy (gating sequence 
as depicted by the arrows): Single cells (SSC-A vs SSC-H), lymphocytes (SSC-A vs FSC-A), γδ 
T cells (A) or CD4 (B) and CellTrace dilution as shown in  Fig. S1 (C and D) Cumulative 
percentage of γδ T cells (C) and CD4 T cells (D) from vaccinated and control animals that 
proliferated in response to mycobacterial antigens, as measured by CellTrace dilution, at 4-, 8- 12- 
or 16-weeks post vaccination. Analysis was performed with Flowjo software. Background 
proliferation was subtracted, and results represent change over mock.  Data represent means ± 
SEM. **p<0.01 ***p<0.001 ****p<0.001 as determined by Student’s t test.  






















































                                              
Figure 13. Circulating and Mucosal M. bovis-specific IFNγ expression in response to in 
vitro restimulation with mycobacterial antigens. 
Approximately ~8 weeks after aerosol vaccination, IFNγ expression was analyzed in circulating 
(PBMC) and in mucosal (BAL) compartment from control (n=7) or BCG–vaccinated animals (n= 
7). 1 x 106 cells/well were stimulated in vitro with PPD-b (200 IU/ml) for 16 hours. Cells were 
then stained for intracellular IFNγ expression and analyzed by flow cytometry. Gating hierarchy 
(gating sequence as depicted by the arrows): Single cells (SSC-A vs SSC-H), lymphocytes (SSC-
A vs FSC-A), γδ or CD4 T cells and IFNγ expression as shown in Fig. S2 and Fig. S3 (A and B) 
The proportions of circulating and mucosal (A) γδ+ IFNγ+ and (B) CD4+ IFNγ+ conditions are 
shown. Analysis was performed with Flowjo software. Data represent means ± SEM. *p<0.05, 
**p<0.01 as determined by Student’s t test.  












Fig. 5. Circulating and Mucosal M. bovis-specific IFNγ 






















           
Figure 14. Phenotype of circulating antigen-specific γδ T cells. 
PBMCs were isolated from calves ~ 8 weeks after BCG vaccination. Cells were stained with 
CellTrace dye and incubated with M. bovis PPD-b for 6 days. Cells were analyzed by flow 
cytometry and the expression of CD45R and CD27 was evaluated on M. bovis-specific 
(proliferating) γδ T cells. (A) Gating hierarchy (gating sequence as depicted by the arrows): Single 
cells (SSC-A vs SSC-H), lymphocytes (SSC-A vs FSC-A), γδ T cells, proliferating (1) and non-
proliferating cells (2) in response to PPD-b and analyzed for CD27 versus CD45R expression. (B) 
Proportion of M. bovis-specific (CellTrace dim; grey bars) and nonspecific (CellTrace bright; 
black bars) γδ T cells in CD45R/CD27 defined subsets (Naïve: CD45R+CD27+; TCM: CD45R-
CD27+; TEM: CD45R-CD27-; TEMRA: CD45R+CD27-). Data are presented as ± SEM. *p < 0.05; 
**p < 0.01, p****<0.0001 indicates a significant difference from antigen-responsive cells 
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Figure 15. Phenotype of mucosal antigen-specific γδ T cells. 
BAL cells were isolated from calves ~8 weeks after vaccination. Cells were stimulated with PPD-
b in vitro for 16 hours. Cells were surface stained and stained for intracellular IFNγ, and then 
analyzed by flow cytometry to evaluate CD45R and CD27 expression on M. bovis-specific γδ T 
cells. (A) Gating hierarchy (gating sequence as depicted by the arrows): Single cells (SSC-A vs 
SSC-H), lymphocytes (SSC-A vs FSC-A), γδ T cells, IFNγ+ (grey bars) and IFNγneg (black bars) 
cells and CD27 versus CD45R expression. (B) Proportion of M. bovis-specific (IFNγ+; grey bars) 
and nonspecific (IFNγneg; black bars) γδ T cells in CD45R/CD27 defined subsets (Naïve: 
CD45R+CD27+; TCM: CD45R-CD27+; TEM: CD45R-CD27-; TEMRA: CD45R+CD27-). Data are 
presented as ± SEM. *p < 0.05, p****<0.0001 indicates a significant difference from antigen-
responsive cells compared to non-responsive cells as determined by Student’s t-test.  

























Fig. 7. Phenotype of mucosal antigen-specific γδ T cells. 
































                      
Figure 16. Surface expression of chemokine receptors on mucosal M. bovis-specific 
circulating γδ and CD4 T cells. 
BAL cells were isolated from calves ~8 weeks after vaccination. Cells were stimulated with 
PPD-b in vitro for 16 hours. Cells were surface stained, stained for intracellular IFNγ expression, 
and the analyzed by flow cytometry for expression of CXCR3. Gating hierarchy (gating 
sequence as depicted by the arrows): Lymphocytes (SSC-A vs FSC-A), γδ T cells or CD4 cells, 
IFNγ+ and IFNγneg cells and CXCR3 as shown in Fig. S4. The left panels depict representative 
histogram plots of CXCR3 expression on M. bovis-specific γδ (A) and CD4 T cells (B). 
Cumulative results from mucosal γδ T cells (A) and CD4 T cells (B) are depicted: relative 
expression (MFI) (middle panels) and the frequency of CXCR3+ cells (right panels) on M. bovis-
specific (grey bars) or M. bovis nonresponsive (black bars). Data are presented as mean ± SEM. 
Not significant (ns), * p < 0.05, **p < 0.01 indicates a significant difference from antigen-






























A Mucosal γδ T cells



































                       
Figure 17. Surface expression of chemokine receptors on circulating M. bovis-specific γδ 
and CD4 T cells. 
(A and B) PBMCs were isolated from calves ~8 weeks after vaccination. Cells were stained with 
CellTrace dye and incubated with PPD-b for 6 days. Cells were surface stained and then analyzed 
by flow cytometry to study CXCR3 and CCR5 expression on circulating M. bovis-specific γδ (A) 
and CD4 T cells (B). Gating hierarchy (gating sequence as depicted by the arrows): Lymphocytes 
(SSC-A vs FSC-A), γδ T cells or CD4 cells, proliferating and non-proliferating cells (CellTrace 
dilution) and CXCR3 or CCR5 expression as shown in Fig. S5. The left panels depict 
representative histogram plots of CXCR3 expression on M. bovis-specific γδ (A) and CD4 T cells 
(B). Cumulative results from blood γδ T cells (A) and CD4 T cells (B) are depicted: relative 
expression (MFI) (middle panels) and the frequency of CXCR3+ cells (right panels) on M. bovis-
specific (grey bars) or M. bovis nonresponsive (black bars). Data are presented as mean ± SEM. 
Not significant (ns), * p < 0.05, **p < 0.01 indicates a significant difference from antigen-























































Fig. 9. Surface expression of chemokine receptors on circulating M. bovis-specific T cells. 
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Current vaccine regimens against TB are ineffective; thus, development of improved 
intervention strategies and a better understanding of the nature of protective immunity remain 
important goals for TB research.  Vaccination via the respiratory tract has been demonstrated to 
induce significant protection against virulent mycobacterial challenge (4-9).  Although Th1 cells 
are of major importance for immunity to TB, other immune populations, notably γδ T cells [(9, 31, 
54, 55) and reviewed (24)], may represent another essential component for the anti-mycobacterial 
immune response.  The focus of this study was to investigate the immunogenicity, and generation 
of systemic and mucosal γδ T cell responses to BCG vaccination via the respiratory tract. 
 Infants are an important target population for TB vaccination.  However, the infant immune 
system represents significant challenges when designing vaccines [reviewed (56)].  There are few 
suitable models suitable for studying infant immunology to TB, and most mucosal TB vaccines 
have been conducted in adult animals.  Although we often attempt to extrapolate our knowledge 
of host defense and vaccine-induces immunity from adults to infants, we currently know little 
about neonatal immune response to mucosal vaccination.  Furthermore, despite the promise of a 
mucosal vaccine strategy, there are safety concerns associated to the administration of a live 
replicating pathogen directly to the respiratory mucosa of immunosuppressed individuals. Thus, a 
reliable animal model that reflects the immune response to this route of vaccination in human 
infants is urgently required.  Here, we observed that aerosol BCG immunization was safe in young 
calves, with no associated lung pathology or clinical symptoms.  Furthermore, we show that 
aerosol BCG immunization of young calves is highly immunogenic and induces antigen-specific 
immune responses in both the systemic and mucosal compartment (Figs. 1 and 2).  Our results are 
consistent with those reported by Hoft et al., showing that oral delivery of BCG to humans induced 
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both systemic and mucosa-associated immune responses in the airways (57).  The capacity of 
mucosal BCG vaccination to induce responses in both the systemic and mucosal immune 
compartments in cattle is in contrast to the observations made in mice, where vaccine responses 
are compartmentalized following mucosal vaccination (58).  In non-human primates, responses 
are less compartmentalized, but the magnitude of response correlates with the route of vaccination, 
with strong systemic responses after systemic vaccination and strong responses in the respiratory 
tract in animals immunized by aerosol delivery (5). Given the limitations of other animal models, 
our results are encouraging and demonstrate the potential of the calf model to evaluate the safety 
and immunogenicity of other TB vaccine candidates through this route of immunization.  
In parallel with efforts to evaluate the safety and immunogenicity of the aerosol route of 
delivery, the identification of immunological correlates of protection is essential to reduce costs of 
challenge experiments and to prioritize vaccine candidates.  Assessing the magnitude and 
frequency of IFNγ-producing CD4 T cells has remained the standard measurement of vaccine 
induced T cell memory for many years.  However, it has become clear recently that this ex vivo 
assay cannot consistently predict vaccine success (59).  Alternatively, long-term cultured IFNγ 
ELISPOT responses to TB vaccination have been shown to negatively correlate with 
mycobacterial burden and TB-associated pathology, and to positively correlate with vaccine 
success (46-49, 60) .  In humans and cattle, the cultured ELISPOT assay is a surrogate of TCM 
responses (39, 47, 48).  Using this assay and the conventional ELISPOT, we evaluated if aerosol 
BCG vaccination was capable of eliciting both effector and TCM responses.  Consistent with the 
results of previous bovine TB vaccine trials examining parenteral BCG vaccination (47, 49), we 
demonstrate here that aerosol BCG vaccination elicits significant long-term cultured IFNγ 
ELISPOT responses to both PPD-b and the protein antigens Tb10.4 and Ag85a (Fig. 3).  Thus 
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aerosol BCG vaccination elicits effector and central memory T cell (TCM) responses in both 
humans and cattle (39, 49, 51, 52). 
In humans, serious TB infection induces expansion of phenotypically immature, TCM 
Vγ9Vδ2 T cells, and a reduction in the pool of Vγ9Vδ2 T cells with immediate effector functions 
(TEM and TEMRA cells), suggesting a functional impairment of γδ T cells perhaps, due to a persistent 
stimulation (61).  Similarly, we have recently reported that virulent M. bovis infection in cattle can 
significantly alter the differentiation of circulating M. bovis-specific γδ T cells towards a TCM 
(CD45R- CD27+CD62Lhi) phenotype (M. Guerra-Maupome, M. V. Palmer, W. R. Waters, J. L. 
McGill, manuscript under review).  In this study, phenotypic analyses of circulating γδ T cells 
showed that M. bovis-specific γδ T cells are strongly affected by BCG vaccination; however, in 
contrast to virulent infection, the vaccine strain induced the expansion of both TCM and TEM γδ T 
cells in the blood (Fig. 6). As particular memory subsets of CD4 T cells have been shown to 
correlate with reduced mycobacterial burden, or to indicate disease progression, we speculate that 
changes in the differentiation status of memory γδ T cell subsets may also be indicative of 
particular disease states or serve as a correlate of immune status.  
Previous reports in humans have shown that TEM γδ T cells are highly represented in sites 
of inflammation and display immediate effector functions (33).  Consistent with these findings, 
BCG vaccination via the respiratory tract was associated with an increase in mucosal IFNγ+  γδ T 
cells (Fig. 5) which exhibited a TEM phenotype (Fig. 7).  In non-human primates, accumulation of 
phosphoantigen-specific Vγ2Vδ2 T cells in the lungs significantly reduces M. tb burden and 
associated lung pathology (9, 28).  Similarly, in mice, M. bovis BCG intranasal infection elicits 
increased levels of IFNγ+ γδ T cells with cytotoxic activity against infected macrophages (41).  
Thus, accumulation of TEM M. bovis-responsive γδ T cells in the airway mucosa may enable an 
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immediate response upon pathogen re-exposure.  Identifying strategies to elicit memory γδ T cell 
differentiation with a high frequency of γδ T cell effectors in the lung, as well as peripheral 
mycobacteria-specific γδ T cells that have the capacity to rapidly traffic into the lung to enhance 
and sustain protection, may be expected to confer optimal vaccine-induced protection (38, 39) 
Few studies have examined γδ T cell chemokine expression (33); however, mycobacterial 
antigen stimulation appears to alter γδ T cell chemokine receptor expression (37).  In our previous 
studies, we have observed increased expression of both CXCR3 and CCR5 on circulating γδ T 
cells from cattle infected with virulent M. bovis (M. Guerra-Maupome, M. V. Palmer, W. R. 
Waters, J. L. McGill manuscript under review).  Similarly, we show here that aerosol BCG 
vaccination is associated with an increase in surface expression of CXCR3 in circulating M. bovis-
specific γδ T cells compared to non-responding cells (Fig. 9).  CXCL10, the ligand of CXCR3, is 
involved in trafficking of Th1 lymphocytes to areas of inflammation.  It has been shown that 
peripheral human Vγ2Vδ2 CXCR3+ T cells are recruited efficiently by CXCL10 (37, 62).  
Moreover, CXCL10 is found in vivo in lymph nodes and TB granulomas (63), suggesting that 
CXCR3 expression in circulating γδ T cells may enable rapid migration to the lungs upon M. bovis 
challenge (64, 65). Interestingly, comparison of CXCR3 expression on circulating T cell 
populations with M. bovis-specific T cells recovered from the BAL on the same day, revealed 
significantly reduced surface expression by both γδ and CD4 T cells in the airways (Fig. 9A and 
B).  These findings are intriguing, as Poggi et al. showed that the homeostatic chemokine CCL21 
was more efficient at inducing transendothelial migration of lung-resident Vγ2Vδ1 CXCR3+ T cell 
populations than inflammatory CXCL10, suggesting that lung-associated γδ T cells preferentially 
respond to homeostatic chemokines, while circulating Vγ2Vδ2 CXCR3+ T cells are more sensitive 
to inflammatory chemokines and thus might not require high expression of CXCR3 (62).  It may 
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also be possible that CXCR3 is internalized or shed by cells which have migrated to the lung, thus 
explaining the reduced surface expression. Functional studies to assess CXCR3-dependent 
lymphocyte trafficking were not performed in this study, thus its importance in facilitating γδ T 
cell recruitment during M. bovis infection in the bovine remains to be fully determined. 
BCG remains the most efficacious, ‘gold-standard’ TB vaccine available to prevent TB in 
humans and animals. Therefore, until improved vaccines are available, it is crucial to identify the 
most effective strategies for using BCG.  As observed here, mucosal vaccination in juvenile calves 
is safe and immunogenic, priming robust effector and memory Mycobacterium-specific T cell 
responses in both peripheral and lung compartment.  Based on our observations, there is merit in 
evaluating this route of immunization using other vaccine candidates, and in employing the infant 
calf model, as it can provide critical insights into mucosal TB-specific immune responses in infant 
humans.  Through a comparative assessment of the phenotype and functions of M. bovis-specific 
γδ T cells in the systemic and mucosal compartment, we have shown that a single BCG 
immunization via the respiratory tract induces differentiation of TCM and TEM M. bovis-responsive 
γδ T cells, with a predominance of TEM γδ T cells in the lungs, where they would be expected to 
mediate immediate effector functions and rapid protection against TB invasion.  γδ T cells are 
known to promote resistance to Mycobacterium infection (9, 10, 32). Thus, engaging γδ T cells 
through novel, aerosol vaccination strategies may be particularly beneficial for promoting local 
protection in the respiratory tract.   
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 ABSTRACT 
Mycobacterium bovis Bacillus Calmette-Guérin (BCG) is a live attenuated vaccine for use 
against tuberculosis (TB); however, it is known to reduce childhood mortality from infections 
other than TB. The unspecific protection induced by BCG vaccination has been associated with 
the induction of memory-like traits of the innate immune system identified as ‘trained’ immunity. 
In humans and mouse models, in vitro and in vivo BCG training leads to enhanced production of 
monocyte-derived proinflammatory cytokines in response to secondary unrelated bacterial and 
fungal pathogens. While BCG has been studied extensively for its ability to induce innate training 
in humans and mouse models, BCG’s nonspecific protective effects have not been defined in 
agricultural species. Here, we show that in vitro BCG training induces a functional change in 
bovine monocytes, characterized by increased transcription of proinflammatory cytokines upon 
restimulation with the toll-like receptor agonists. Importantly, in vivo, aerosol BCG vaccination in 
young calves also induced a ‘trained’ phenotype in circulating peripheral blood mononuclear cells 
(PBMCs), that lead to a significantly enhanced TLR-induced proinflammatory cytokine response 
compared to PBMCs from unvaccinated control calves. Our results show that BCG training not 
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only induces increased cytokine production but also identifies glycolysis as a fundamental 
molecular basis. Similar to the long-term training effects of BCG reported in humans, our results 
suggest that in young calves, the effects of BCG induced innate training can last for at least 3 
months in circulating immune populations. Interestingly, however, aerosol BCG vaccination did 
not ‘train’ the innate immune response at the mucosal level, as alveolar macrophages from aerosol 
BCG vaccinated calves did not mount an enhanced inflammatory response to secondary 
stimulation, compared to cells isolated from control calves. Together, our results suggest that, like 
mice and humans, the innate immune system of calves can be ‘trained’; and that BCG vaccination 
could be used as an immunomodulatory strategy to reduce disease burden in juvenile food animals 




Evidence from epidemiological studies suggests that previous exposure to Mycobacterium 
bovis Bacillus Calmette-Guérin (BCG), a live attenuated vaccine used to prevent tuberculosis, 
reduces the risk of childhood mortality due to prevention of sepsis, diarrhea and respiratory 
infections [(1-4) and reviewed (5, 6)].  It has been suggested that the nonspecific disease resistance 
induced by BCG is mediated by an enhanced memory-like response of the innate immune system 
known as ‘trained’ immunity (7, 8).  
Trained immunity is induced primarily in myeloid cells (monocytes and macrophages) and 
natural killer (NK) cells (8-11), after previous exposure to some live vaccines like BCG, measles 
and yellow fever, as well as to some microbial components of pathogens (11-17), which results in 
superior cytokine expression and ultimately, enhanced capacity to prevent infection. Mechanistic 
studies have demonstrated that trained immunity is independent of adaptive immunity (18), and is 
caused by epigenetic reprogramming and alterations in basal intracellular metabolic pathways, 
which result in changes in gene expression and cell physiology leading to increased innate immune 
cells’ capacity to respond to stimulation (9, 10, 16).  
Evidence that trained immunity mediates the nonspecific protective effects seen after BCG 
vaccination came from proof-of-principle experimental studies.  In these studies, BCG vaccination 
of severe combined immunodeficiency (SCID) or recombination-activating gene 1 (rag1)-
deficient mice induced protection against subsequent lethal Candida albicans (C. albicans) 
infection via a mechanism that requires macrophages and proinflammatory cytokine production, 
both prototypical innate immune components (9, 16, 19).  Mice vaccinated with BCG also show 
increased resistance to malaria infection, which is associated with increased transcription of 
antimicrobial proteins compared with nonvaccinated mice (20).  
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In humans, BCG vaccination leads to an enhanced production of the monocyte-derived 
proinflammatory cytokines, tumor necrosis alpha (TNFa) and interleukin 6 (IL-6), in response to 
unrelated bacterial and fungal pathogens (C. albicans, Staphylococcus aureus) (16); and superior 
NK cell activity (11).  Moreover, in neonates, intradermal BCG vaccination at birth influences the 
responses to common vaccine antigens at the systemic level, which appeared to be mediated 
through activation of T lymphocytes by APCs (21).  Similarly, compared with unvaccinated 
babies, cord blood monocytes from BCG vaccinated infants show increased expression of 
granulysin and perforin upon stimulation (22).  Taken together, these observations suggest that 
BCG vaccination has the capacity to train the innate immune system to develop memory-like traits 
that result in enhanced disease resistance. 
The nonspecific protection afforded by parenteral administration of some live vaccines is 
increasingly appreciated as an aspect of innate immunity that can be exploited for enhancing 
disease resistance in subjects at high risk from infections (23).  Similar to young human infants, 
neonatal and juvenile agricultural species are most susceptible to respiratory diseases during the 
first weeks of life, due to waning maternal immunity and the still-developing neonatal adaptive 
immune system. In cattle, nearly a quarter of pre-weaned deaths and nearly half of postweaning 
calf deaths can be attributed to respiratory diseases, with calf pneumonia affecting as many as 20-
30% of calves in some operations (24, 25).  Therefore, methods to enhance disease resistance and 
limit pathogen colonization are highly needed to reduce the risk of respiratory disease in calves, 
which also serve as valuable animal model for juvenile human respiratory diseases. 
The mucosal surface of the respiratory tract represents the principal portal of entry for most 
human and animal pathogens. It is believed that matching the route of infection with the route of 
vaccination will provide the best protection against disease (26).  Thus, there are ongoing efforts 
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to evaluate mucosal routes of vaccination (i.e. intranasal or aerosol) for delivery of live respiratory 
pathogens (27).  BCG vaccination of juvenile calves is a well-described model that has been used 
previously to explore the adaptive immune response to bovine tuberculosis; and to model the 
human infant immune response to TB infection (28-31).  Aerosol vaccines have not only the 
immunological advantage of being able to replicate in the respiratory mucosa and prime the 
mucosal immune system, but also have practical and logistical advantages (32).  However, few 
studies have looked at the ability of this route to induce a ‘trained’ immune phenotype at mucosal 
surfaces, at which there may be a more efficient route of inducing memory-like innate responses 
against mucosal diseases.  Therefore, using the calf model of aerosol BCG vaccination, the 
objective of this study was to test the hypothesis that both in vitro and in vivo BCG exposure will 
‘train’ bovine innate immune cells to develop memory-like characteristics against unrelated 
secondary stimuli, and thus can be harnessed as an approach to reduce disease burden in juvenile 
food animals.   
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MATERIALS AND METHODS 
Animal Use Ethics  
All animal procedures were conducted in strict accordance with federal and institutional 
guidelines and were approved by the Kansas State University Institutional Animal Care and Use 
Committee (Protocol Number: 27-2956).  All the animals in this study, were housed in pens outside 
at Kansas State University in Manhattan, KS.  Animals had ad libitum access to hay, water, and 
concentrate.  The animal care protocol included avoidance of prolonged restraint, and methods to 
minimize pain and distress as determined by the discretion of the attending clinical veterinarian.  
No animals died or required euthanasia.  For the in vitro studies, peripheral blood was collected 
from a total of six Holstein heifers (one-two years old). 
For the vaccine study, fourteen, 6-8-week-old Holstein bull calves were randomly assigned 
to two groups (n = 7 animals/group): vaccinated and unvaccinated group.  Clinical signs like 
cough, dyspnea, and appetite were monitored daily throughout the study.  No adverse effects from 
immunization were observed.  Peripheral blood and broncheoalveolar lavage samples were 
collected at 4 and 12 weeks postvaccination for evaluation of peripheral and mucosal immune 
responses, respectively.  
 
Bacterial culture 
M. bovis BCG Danish strain was a gift from Dr. Ray Waters at the National Animal Disease 
Center, USDA.  BCG was prepared using standard techniques in Middlebrook 7H9 liquid media 
(Becton Dickinson, Franklin Lakes, NJ) supplemented with 10% oleic acid-albumin-dextrose 
complex (OADC) plus 0.05% Tween 80 (Sigma, St. Louis, Missouri).  For in vitro and in vivo 
experiments, bacteria in log phase were centrifuged (3000 rpm for 15 minutes) and resuspended 
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in cRPMI without antibiotics for in vitro studies, or sterile PBS for in vivo vaccination studies (see 
below for additional details).  
 
Peripheral blood mononuclear cell preparation, cryopreservation and monocyte isolation 
Peripheral blood was collected into 2x acid citrate dextrose via the jugular vein.  Peripheral 
blood monocular cells (PBMCs) were isolated from buffy coats by density centrifugation as 
previously described (33).  Contaminating red blood cells were removed using hypotonic lysis. 
Cells were washed three times, counted and resuspended in complete RPMI (cRPMI) composed 
of RPMI-1640 (Gibco, Carlsbad, CA) supplemented with 2 mM L-glutamine, 25 mM HEPES 
buffer, 1% antibiotic-antimycotic solution, 1% non-essential amino acids 2% essential amino 
acids, 1% sodium pyruvate, 50 µM 2-mercaptoethanol (all from Sigma, St. Louis, MO), and 10% 
(v/v) fetal bovine sera (FBS). 
PBMCs from the vaccine study where cryopreserved as follows: briefly, PBMCs were 
resuspended at 2 x107 cells/mL in 1 mL of precooled FBS containing 10% dimethyl sulfoxide 
(DMSO), and rapidly brought to −80°C in polystyrene containers, which ensured a slow drop in 
temperature.  After 24 h, the cryovials were transferred to a liquid nitrogen tank where they 
remained until analysis. 
Monocytes were isolated using Magnetic Activated Cell Sorting (MACS) according to 
manufacturer’s instructions.  Briefly, PBMCs were resuspended at 107 cells/mL in MACS buffer 
(0.5% BSA, 2mM EDTA in PBS) and labeled with 10 µg/mL mouse anti-bovine CD14 (Clone 
CAM36A) from Washington State Monoclonal Antibody center (Pullman, WA) for 20 min at 4°C. 
Cells were then washed and labeled with anti-mouse IgG1 magnetic beads (Miltenyi Biotech) and 
purified by positive selection.  
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Bronchoalveolar lavage fluid collection, cell isolation and cryopreservation  
Broncheoalveolar lavage (BAL) samples were collected from the group of calves in the 
vaccine study (n = 7/ group) at 4 weeks post immunization.  A modified stallion catheter was 
blindly passed through the nose and advanced through the trachea until lodging in the bronchus.  
A total of 180 mL of sterile saline was divided into three aliquots.  An aliquot was introduced to 
the lower respiratory tract, followed by immediate suction to obtain lower airway washes. The 
procedure was repeated twice more.  All three aliquots were pooled at the end of the procedure.  
BAL samples were kept on ice, filtered over sterile gauze, and centrifuged at 200 x g for 10 
minutes.  Contaminating red blood cells were removed using hypotonic lysis. Cells were washed, 
counted and cryopreserved as described above.  
 
In vitro training model in bovine monocytes  
In vitro immune training was performed as described previously (16, 34) (Fig. 1A). Briefly, 
isolated bovine monocytes were plated in a total volume of 200 µl/well of cRPMI, at a 
concentration of 1x105 cells/well in flat-bottom, 96-well tissue-culture-treated plates (Falcon). 
Monocytes were incubated with culture medium only as a negative control.  Cells were infected at 
a 5:1 multiplicity of infection (MOI) with BCG strain Danish for 24 hours at 37° C/5% CO2, 
washed once with warm culture media, resuspended in cRPMI and incubated for 6 days.  The 
media was replaced once, at day 3. After the incubation, the media was removed and cells were 
re- stimulated with cRPMI, E. coli lipopolysaccharide (LPS; serotype 055:B5; Sigma-Aldrich, 1 
µg/mL), tripalmitoylated lipopeptide (Pam3CSK4; InvivoGen, 10 µg/mL) or 
polyinosinic:polycytidylic acid (Poly(I:C); InvivoGen, 10 µg/mL) for 4 hours (mRNA expression) 
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or 72 hours (protein expression).  After the indicated times, cells were pelleted, supernatants 
collected for cytokine measurement and cells lysed with Trizol Reagent (Invitrogen, Life 
Technologies) for mRNA transcription assessment and stored at -80°C.  
 
In vivo experiments  
BCG vaccination  
For the vaccine study, each calf in the vaccinated group (n = 7) received 1x108 colony-
forming units (CFU) of Mycobacterium bovis BCG strain Danish via aerosol inoculation as we 
have previously described (35).  Briefly, the inoculum was nebulized into a mask (Trudell Medical 
International, London, ON, Canada) covering the nostrils and mouth, allowing regular breathing 
and delivery of the mycobacteria to the lungs via the nostrils. 
 
Thawing and ex vivo stimulation  
For thawing, PBMCs or alveolar macrophages were removed from the liquid nitrogen and 
thawed in a 37°C water bath for 2 minutes.  Once thawed, the cells were rapidly transferred to 15-
ml polystyrene tubes containing 8 ml of warm cRPMI to remove DMSO.  Finally, the cells were 
washed twice with complete medium and counted.  Cell viability was assessed using Trypan Blue 
method and found to be >85%.  For stimulation experiments, PBMCs or BAL cells (1x106 
cells/mL, 1 mL/well) were added to 24-well, tissue-culture-treated plates and rested overnight at 
37°C, 5% CO2.  Cell cultures were then washed once with warm cRPMI, and the cells were 
stimulated with cRPMI (negative control), LPS, Pam3CSK and incubated for 4 hours (mRNA 
expression) or 72 hours (protein expression).  After the indicated times, cells were pelleted, and 
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lysed with Trizol Reagent (Invitrogen, Life Technologies) or cell culture supernatants were 
collected, and stored at −80°C.  
 
Real-time PCR 
RNA isolation, cDNA preparation and qPCR were performed as described (33). The primer 
sequences have been published (36, 37) (Table 1).  Relative gene expression was determined using 
the 2−ΔΔCt method, with RPS9 as the reference housekeeping gene (38).  Reactions were performed 
on an Agilent MX3000P Real-Time PCR machine or Quantstudio 3 Real-Time PCR machine.  The 
following amplification conditions were used: 2 min at 50°, 10 min at 95°, 40 cycles of 15 seconds 
at 95° and 1 min at 60°, and a dissociation step (15 seconds at 95°, 1 min at 60°, 15 seconds at 95°, 
15 seconds at 60°).  
 
ELISAs 
The concentration of cytokines in cell culture supernatants was determined after 72 hours 
of incubation, using bovine commercial ELISA kits for interleukin-1 beta (IL-1β), tumor necrosis 
factor alpha (TNF-α), and IL-6 (all from Kingfisher Biotech, Inc., St. Paul, MN) according to 
manufacturer’s instructions.  
 
Flow cytometry  
For flow cytometric analysis, PBMC were added to 96-well round bottom plates (1X106 
cells/well). Staining was performed at 4°C.  Cells were labeled for 25 minutes with Live/Dead 
Aqua (Thermo Fisher) and 10 µg/mL of the following primary antibodies: mouse anti-bovine 
CD14 (clone CAM36A) and CD11b (clone MM10A) from Washington State Monoclonal 
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Antibody center.  Cells were washed once, and then incubated for 25 minutes with 0.5 ug/mL of 
the following secondary antibodies: PeCy7 (IgG1, Biolegend) and APC-Cy7 (IgG2b, Southern 
biotech).  Samples were acquired using a BD LSR Fortessa flow cytometer (BD Biosciences). 
Data were analyzed using FlowJo (Tree Star Inc., San Carlos, CA).  
 
Metabolite measurements  
 The concentration of glucose and lactate in cell culture supernatants was determined after 
72 hours of incubation, using Glucose Colorimetric Assay Kit (Catalog # K06-100, Biovision) 
and Lactate Colorimetric Assay Kit (Catalog # K07-100, Biovision), respectively.  
 
Statistics  
2-ΔΔCt method was used in the statistical analysis of relative gene expression (shown as 
expression relative to uninfected or unstimulated control samples).  Statistical comparisons were 
performed using One-way ANOVA followed by Tukey’s multiple comparison test. p value below 
0.05 was considered statistically significant.  All data were analyzed using GraphPad Prism 















IL-6 CTGAAGCAAAAGATCGCAGATCTA CTCGTTTGAAGACTGCATCTC NM_173921.2 
IL-1b TTCTGTGTGACGCACCCGTGC AGCACACATGGGCTAGCCAGC X54796 
TNFa CGGGGTAATCGGCCCCCAGA GGCAGCCTTGGCCCCTGAAG NM_174088.1 
RPS9 CGCCTCGACCAAGAGCTGAGG CCTCCAGACCTCAGGTTTGTTCC NM_001101152 
TLR2 CGATGACTACCGCTGTGACTC CCTTCCTGGGCTTCCTCTT NM_174198.6 
TLR4 TGCCTTCACTACAGGGACTTT TGGGACACCACGACAATA AC NM_174197.2 




In vitro BCG priming induces trained bovine monocytes, characterized by increased 
transcription of proinflammatory cytokines 
In vitro BCG priming induces enhanced proinflammatory cytokine expression in response 
to unrelated antigens in murine and human monocytes (11, 16, 34, 39).  To test if bovine monocytes 
have the capacity for innate training, we utilized a traditional in vitro protocol of trained immunity 
(Fig. 18A) (16, 34).  Circulating bovine monocytes were isolated from peripheral blood and 
exposed to BCG in vitro for 24 hours, rested for 6 days and stimulated with unrelated microbe-
associated molecular patterns (LPS, Poly(I:C) or Pam3CSK4). RT-PCR was used to analyze 
changes in gene expression of IL-6 and TNFa.  As shown in Fig. 18B, bovine monocytes primed 
in vitro with BCG mounted an enhanced response to LPS or Pam3CSK4 compared to non- trained 
cells, characterized by higher expression of TNFa and IL-6. Interestingly, cells exposed to BCG 
did not mount an enhanced response following secondary exposure to Poly(I:C) (data not shown).  
These results suggest that, similar to observations in humans and mice models (16, 34, 39), in vitro 
BCG priming of bovine monocytes induces increased responsiveness to secondary unrelated 
stimuli, as measured by expression of the proinflammatory cytokines TNFa and IL-6. 
 
BCG vaccination of young calves induces enhanced nonspecific production of monocyte-
derived proinflammatory cytokines.  
Previous studies have demonstrated that parenteral BCG immunization in healthy adult 
humans enhances the immune response of peripheral monocytes, macrophages and NK cells upon 
subsequent ex vivo peripheral blood mononuclear cell restimulation (11, 16, 40).  Therefore, we 
next determined if BCG vaccination also had the capacity to train peripheral mononuclear cells in 
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calves.  To explore the possible impact of mucosal immune training on the juvenile immune 
system, we employed an aerosol route of BCG vaccination for our studies. A total of 14 calves 
were divided into two groups (n = 7 animals/group).  The vaccinated group received 1x108 cfu 
BCG strain Danish via aerosol inoculation (Fig. 19A).  The remaining calves served as 
unvaccinated controls.  Four weeks after vaccination, PBMCs were isolated and restimulated in 
vitro with LPS or Pam3CSK4 for 4 hours (mRNA expression) or 72 hours (protein expression). 
As shown in Fig. 19B and 19C, PBMC from calves receiving in vivo BCG vaccination 
demonstrated significantly enhanced expression of the monocyte-derived proinflammatory 
cytokines IL-6, Il-1b and TNFa, in response to ex vivo stimulation with LPS and Pam3CSK.  
Together, our results confirm previous reports in human and murine species, showing that BCG 
vaccination induces an hyperresponsive state in bovine circulating mononuclear cells, 
characterized by the enhanced production of monocyte-derived proinflammatory cytokines upon 
secondary stimulation with unrelated antigen.  Our results also confirm the ability of BCG to 
induce memory-like innate immune traits in early life. 
 
BCG vaccination increases glucose consumption and lactate production in bovine trained 
monocytes  
 Studies have suggested that trained immunity has a molecular basis as an underlying 
mechanism, which relies upon specific epigenetic reprogramming that affect immune signaling 
pathways and cellular metabolism (8-10, 43).  Here we observed that when bovine PBMCs form 
aerosol BCG-vaccinated animals were stimulated in vitro with LPS or Pam3CSK4 for 72 hours 
the amount of glucose and lactate production was significantly higher than PBMCs from 
unvaccinated animals (Fig. 20).  Our findings are consistent with human monocytes trained with 
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b-glucan where a metabolic switch from oxidative phosphorylation to glycolysis has been 
described (41).  Thus, results observed here are compatible with the hypothesis that elevated 
glycolysis is the metabolic basis for trained immunity in BCG-vaccinated animals.  
 
Aerosol BCG immunization does not alter the number of circulating bovine monocytes or 
activation marker expression 
Compared to cells from non-vaccinated individuals, monocytes and NK cells from BCG-
vaccinated human adults and infants display slightly increased expression of the surface markers 
CD14, CD11b and Toll-like receptor 4 (TLR4); but no changes in TLR2 or dectin-1 (11, 16). To 
further characterize the phenotype of trained bovine monocytes induced by BCG vaccination, we 
measured the expression of surface markers by flow cytometry.  As seen in Fig. 3A, no differences 
were detected in the frequency of CD14+ cells or in the surface expression of CD11b+ between 
vaccinated and unvaccinated calves.  Similarly, TLR4 and TLR2 mRNA expression did not differ 
between groups at 4 weeks after vaccination (Fig. 20B-C).  In accordance with our results, 
blocking of TLR4 or TLR2 during preincubation with live BCG did not significantly influence the 
magnitude of trained immunity in mice (42).  
 
BCG vaccination induces a long-term ‘trained’ phenotype in bovine PBMCs. 
The effects of BCG vaccination on innate immune training have been shown to persist for 
at least 3 months to a year (6, 16, 40).  As seen in Fig. 21, BCG vaccination also leads to long-
term functional changes in bovine peripheral mononuclear cells. PBMC isolated 12 weeks after 
vaccination displayed enhanced production of proinflammatory cytokines IL-6, IL-1b and TNFa 
in response to LPS and Pam3CSK4 compared to the unvaccinated group (Fig. 21B).  
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Bovine alveolar macrophages do not adapt a ‘trained’ phenotype in response to aerosol 
BCG vaccination 
Respiratory infections are a major cause of juvenile human and animal morbidity and 
mortality. In the lung, alveolar macrophages (AMs) are the most abundant immune-cell type 
present under homoeostatic conditions (43).  Considering that BCG influences the functional state 
of circulating monocytes, and that AMs are critical in immunity to respiratory infections, we 
hypothesized that aerosol BCG vaccination could induce functional changes at the level of the 
respiratory mucosa, that could enhance the AMs immune properties.  Therefore, we collected BAL 
samples at 4 weeks post aerosol BCG vaccination. Alveolar macrophages were plated at 1x105 
cells/well in 24-well plates and stimulated in vitro with LPS or Pam3CSK4 for 4 hours (mRNA 
expression) or 72 hours (protein expression).  As shown in Fig. 22B-C, compared to the control 
group, aerosol exposure of BCG did not impact gene and protein expression of the 
proinflammatory cytokines, IL-6, Il-1b or TNFa, in response to ex vivo stimulation with LPS and 
Pam3CSK4.  These results indicate that aerosol BCG vaccination does not ‘train’ alveolar 




                               
Figure 18. In vitro BCG infection of bovine monocytes enhances the expression of 
proinflammatory cytokines after stimulation with LPS or Pam3CSK4. 
(A) Diagram of the in vitro training model used in bovine isolated monocytes. (B) IL-6 and TNFα 
expression after restimulation for 4 hours. Monocytes isolated from peripheral blood of six healthy 
heifers were plated at 1x106 cells/mL in a 96-well plate. Cells were infected in vitro with BCG at 
a MOI of 5:1 for 24 hours, washed once with warm cRPMI, incubated for 6 days, and stimulated 
with LPS, Poly(I:C) or Pam3CSK4 for 4 hours. Uninfected cells (cRPMI) served as negative 
controls. Changes in gene expression were assessed by RT-PCR. Data represent means ± SEM 
(n=6). *p<0.05. 
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Figure 19. BCG vaccination increased nonspecific production of monocyte-derived 
proinflammatory cytokines. 
(A) Diagram showing the BCG vaccination schedule in calves. Calves were vaccinated with 1 x 
108 colony forming units (CFU) BCG Danish via aerosol. Peripheral blood was collected four 
weeks post vaccination from calves in both groups. (B) PBMCs isolated from calves after four 
weeks post vaccination, were stimulated in vitro with LPS or Pam3CSK4 for 4 or 72 hours to 
measure cytokine expression. Proinflammatory cytokine gene expression was assessed by RT-
PCR (B), and protein expression was assessed by ELISA on the cell supernatants (C). Data 
represent means ± SEM. *p<0.05, **p<0.01. 
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Figure 20. BCG vaccination increases glucose consumption and lactate production in bovine 
trained monocytes. 
Peripheral blood was collected four weeks postvaccination from calves in both groups.  PBMCs 
were stimulated in vitro with LPS or Pam3CSK4 for 72 hours to measure glucose and lactate 
concentration in cell culture media using Glucose Colorimetric Assay Kit (Catalog # K06-100, 
Biovision) and Lactate Colorimetric Assay Kit (Catalog # K07-100, Biovision), respectively. (A) 
Changes of glucose consumption and lactate production (B) of PBMCs from unvaccinated (grey 
bars) and BCG vaccinated animals (black bars).  Data represent means ± SEM. No significant 
(NS), *p<0.05, **p<0.01, *** p<0.001. 
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Figure 21. BCG aerosol immunization does not alter the frequency or surface marker 
expression of bovine circulating monocytes. 
(A) Flow cytometric analysis of circulating CD14+ CD11b+ monocytes isolated 4 weeks after 
BCG immunization. Average frequencies of CD14+ CD11b+ cells isolated from both groups of 
calves (n = 7/group). (B) Monocytes were isolated as described in Materials and Methods section 
and analyzed by RT-PCR for the mRNA expression of TLR2 and TLR4, after 4 weeks of BCG 
vaccination. Data represent means ± SEM. No significant (NS) differences were observed between 
treatment groups. 
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Figure 22. BCG vaccination induces long-term ‘trained’ phenotype in bovine PBMCs. 
PBMCs isolated from calves after twelve weeks postvaccination, were stimulated in vitro with 
LPS or Pam3CSK4 for 4 or 72 hours to measure cytokine expression. Proinflammatory cytokine 
gene expression was assessed by RT-PCR (A) and protein expression was assessed by ELISA in 
the supernatants (B). Data represent means ± SEM. No significant (NS), *p<0.05, **p<0.01, *** 
p<0.001. 
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Figure 23.BCG aerosol vaccination does not alter the function of alveolar macrophages. 
Calves were vaccinated with 1x108 colony forming units (CFU) BCG Danish via aerosol. 
Peripheral blood was collected four weeks post vaccination from calves in both groups.  PBMCs 
isolated from calves after four weeks post vaccination, were stimulated in vitro with LPS or 
Pam3CSK4 for 4 or 72 hours to measure cytokine expression.  Proinflammatory cytokine gene 
expression was assessed by RT-PCR (A), and protein expression was assessed by ELISA in the 
supernatants (B). Data represent means ± SEM. No significant (NS), *p<0.05. 
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BCG parenteral vaccination has long been known to have beneficial effects against 
childhood diseases other than TB, and it has recently become clear that these effects arise through 
a mechanism known as innate training or ‘trained’ immunity (7, 8, 16).  However, the nonspecific 
effects of BCG have yet to be studied in agricultural species. Here, we demonstrate that, consistent 
with previous studies in human and mouse models (11, 16, 29, 32, 33), BCG vaccination has the 
capacity to ‘train’ bovine PBMCs, leading to a significantly enhanced TLR-induced 
proinflammatory cytokine response compared to PBMCs from control calves (Fig. 2).  Thus, our 
observations have important clinical relevance, as they suggest that the use of BCG vaccination is 
likely to confer improved disease resistance, through at least 6 months of age, when the ‘window 
of susceptibility’ to infection with common diseases in juvenile animals is greatest.  
In agreement with data obtained in plants and invertebrates, studies have suggested that 
trained immunity has a molecular basis as an underlying mechanism, which relies upon specific 
epigenetic reprogramming that affect immune signaling pathways and cellular metabolism (8-10, 
44).  In this study, we identify metabolic pathways induced in bovine PBMCs by aerosol BCG 
vaccination, demonstrating a metabolic switch toward aerobic glycolysis (Fig. 5).  Similarly, 
earlier studies reported that cell activation and proliferation induced a switch toward aerobic 
glycolysis in macrophages (45).  Subsequent studies in human monocytes, identified a similar 
metabolic switch after b-glucan priming that involve distinct histone methylations at H3K4 mark 
with chromatin remodeling at a subset of cytokine promoters that lead to transcriptional programs 
associated with genes of the mTOR pathway (10, 16, 41).  To our knowledge our study is the first 
to identify the glycolytic process induced by BCG training in vivo.  Our results show that BCG 
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training not only induces increased cytokine production but also identifies glycolysis as a 
fundamental molecular basis.  
There is little information on the duration of the transcriptional changes provided by trained 
immunity.  Regarding trained immunity in monocytes, epidemiological studies in children have 
shown that BCG vaccination induces nonspecific protection for at least the duration of early 
childhood (46).  Considering the short half-life of circulating monocytes, this suggests that the 
epigenetic reprogramming occurs in the bone marrow progenitors (17, 47).  Identification of core 
signatures of innate training is thus important, as it allows the better characterization of these 
functional states, and may have consequences in the selection of antigens, development of 
adjuvants and vaccine design. 
In addition to epigenetic reprogramming, the functional modulation of monocytes, 
macrophages and NK cells during trained immunity has been linked to an slightly increased 
expression of PRRs and activation markers crucial for pathogen recognition such as CD14,  
CD11b, and Toll-like receptor 4 (TLR4), but no changes in TLR2 or dectin-1 (11, 16). In our 
study, no differences were detected in the frequencies of circulating monocytes (CD14+), or in the 
surface expression of CD11b+ between vaccinated and unvaccinated calves.  Also, TLR4 and 
TLR2 mRNA expression did not differ between BCG-vaccinated and control calves 4 weeks after 
vaccination (Fig. 3A-C).  In accordance with our results, blocking of TLR4 or TLR2 during 
preincubation with live BCG did not significantly influence the magnitude of trained immunity in 
mice (42), suggesting that the ‘trained’ phenotype is likely not simply due to increased expression 
of PRR or other surface activation markers.  A limitation of our study is that we did not investigate 
the molecular mechanism by which trained immunity was induced in bovine cells.  However, 
epigenetic alterations that facilitate gene transcription has been demonstrated to a mechanism that 
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influences the ‘trained’ immune response to secondary stimulation in other models (9-11, 16, 17).  
While this was beyond the aims of the present study, future experiments in cattle should aim to 
identify the epigenetic program induced after BCG priming, as it an important question that will 
allow better characterization of these functional states. 
The mucosal surface of the respiratory tract represents one of the principal portals of entry 
for most human and animal pathogens.  Juvenile agricultural species, similar to young human 
infants, are most susceptible to respiratory diseases during the first weeks of life, as the adaptive 
immune system develops.  Alveolar macrophages (AMs) have an essential role in lung innate 
immunity and in protecting the host against respiratory diseases (43). AMs fulfil a variety of 
functions including, removal of cellular debris, immune surveillance, microbial clearance, 
responses to infection and the resolution of inflammation.  Given that AMs are an important 
regulator of the local innate response against respiratory pathogens, it is logical to assume that 
enhanced function may be a more efficient at reducing the risk of respiratory infections and thus, 
reducing juvenile mortality.  However, few studies have looked at the ability to induce an immune 
‘trained’ phenotype in AMs.  In the current study, we assessed if aerosol BCG vaccination induces 
functional changes at the level of the respiratory mucosa that could alter the functional properties 
of AMs.  As shown in Fig. 6B-C, our data demonstrate that AM’s from BCG-immunized calves 
do not adopt a ‘trained’ phenotype in response to ex vivo stimulation with LPS and Pam3CSK4.  
Similar to our results, a low dose of intranasal administration of BCG (TICE strain) in mice has 
been shown to result in decreased TNF-α mRNA expression and increased IL-10 mRNA 
expression in AMs (48).  We speculate that the inability to induce a ‘trained’ phenotype in AM’s 
after BCG vaccination is related to the inherent immunosuppressive properties of AM and the lung 
environment, as demonstrated by the upregulation of IL-10 in mice (43, 48).  The type of 
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hyperresponsive innate immune state induced by innate training has beneficial effects during host 
defense, as showed in epidemiological studies, but it could also trigger enhanced tissue damage 
(49).  It is worth to mentioning, however, that although AMs from mice in the study of Mukherjee 
et. al. exhibits an immunosuppressive phenotype, the animals were still protected against a lethal 
infection with mouse-adapted influenza virus A/Puerto Rico/8/34 (PR8) (H1N1) after intranasal 
BCG vaccination (48).  Moreover, the nasal route of BCG immunization was more effective than 
the systemic route against the respiratory challenge.  The authors hypothesize that this enhanced 
resistance is due to increased efferocytosis in animals receiving intranasal BCG vaccination.  Thus, 
limiting immune responses to foreign antigens may be an essential form of adaptation that reduces 
tissue damage in sites where high pathogen burden occurs, and thus may be an aspect of lung 
tolerance and resistance to infection.  Future studies should be aimed at comparing different routes 
of immune training (parenteral or mucosal), identifying possible therapies that induce mucosal 
innate training of AMs, and determining the potential of mucosal ‘trained’ immunity to prevent 
respiratory infection.  
 Epidemiological studies show that the nonspecific effects of BCG vaccination are most 
pronounced in the first year of life, suggesting that trained immunity is most strongly activated 
during this first year (1, 2).  However, few immunological studies in human infants and neonates 
have been performed, due to ethical concerns and difficulty obtaining samples.  Thus, the full 
spectrum of innate training and its capacity to promote disease resistance in children has not been 
fully explored.  The calf represents an excellent translational model to investigate the effect of 
BCG vaccination on susceptibility to common respiratory diseases, as it is a tractable model of the 
infant immune system and allows for the longitudinal collection of large volumes of peripheral 
blood and BAL fluid that can be used for cytological, immunological or virological studies.  Thus, 
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studies in the calf could benefit both human and animal health and provide information to develop 
novel vaccination strategies that would more effectively induce both classic adaptive immunity 
and innate trained immunity to reduce the incidence of common pathogens.  
  In conclusion, although the effects of BCG on trained immunity have been described 
before, we provide evidence for the first time that in the young calf, in vivo BCG training induces 
memory-like traits comparable to what has been described in adult human volunteers and mouse 
models.  While BCG vaccination might not be an ideal agent to use for innate training in 
agricultural species due to regulatory concerns (i.e. skin-testing for monitoring M. bovis infection), 
our results warrant further research to identify the microbial components of BCG capable of 
combining effective induction of adaptive immune responses with elicitation of trained immunity, 
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Chapter 5 - SUMMARY AND FUTURE DIRECTIONS 
 
In the studies described here I describe a system in which infection with M. bovis generates 
memory-like responses in bovine immune cells.  In the first part of my research, I characterized 
bovine M. bovis-specific γδ T cell effector/memory subsets by the development of a defined, 
surface marker expression panel, similar to previously reported in non-human primates and 
humans (1, 2).  Following M. bovis infection, a marked in vitro expansion of γδ T cells suggests 
that bovine γδ T cells can mount memory-like responses upon restimulation with mycobacterial 
antigen.  Further, I demonstrate that virulent M. bovis infection modulates peripheral γδ T cell 
responses, and elicits phenotypic characteristics consistent with that of TCM (CD45R- CD27+) 
cells (3, 4).  Contrary to virulent infection, attenuated M. bovis BCG infection elicited both γδ 
TEM (CD45R- CD27-) and TCM (CD45R- CD27+) subsets in peripheral blood, suggesting that 
mycobacterial virulence may influence γδ T cell memory differentiation.  In particular, the antigen-
specific γδ T cell response in the mucosal compartment following BCG infection showed a unique 
modulation of surface markers characteristic of γδ TEM (CD45R- CD27-) cells when stimulated 
with antigen compared to that which occurred in the peripheral compartment.  Together with the 
phenotypic expression of memory markers CD45R and CD27 our results indicate that in the 
bovine, antigen-specific γδ T cells can be characterized of TCM and TEM subsets based on the 
expression of those markers in CD4 T cells.  Our observations on chemokine modulation, also 
provide some insight into the mechanism utilized by antigen-specific γδ T cells to rapidly localize 
to sites of inflammation at early stages of the granuloma development.   
Our results appear to be consistent with observations in patients with  active TB, were TEM 
γδ T cells are reduced in peripheral blood, and are successfully reestablished to basal levels after 
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drug therapy (4, 5).  Moreover, expansion of TEM γδ T cells through vaccination or 
phosphoantigen administration correlates with protection against fatal TB in non-human primates 
(6-9).  In recent work by Shen et al., they demonstrate that selective activation of Vγ2Vδ2 T cells 
in vivo with a single respiratory administration of phosphoantigen (E)-4-hydroxy-3-methyl-but-2-
enyl pyrophosphate (HMBPP)-producing attenuated Listeria monocytogenes (Lm ΔactA prfA*), 
elicited robust Vγ2Vδ2 T cell expansion, Th1-like responses, and reduced TB pathology after 
moderate-dose TB challenge.  In this study, analysis of antigen-specific Vγ2Vδ2 T cells revealed 
that protection correlated with rapid memory-like, Th1-like Vγ2Vδ2 T cell response, the presence 
of tissue-resident Vγ2Vδ2 T effectors coproducing IFNγ and perforin, inhibition of intracellular 
M. tb growth, and enhanced CD4 and CD8 T cell responses (8).   
These observations together with those described here, suggest that the capacity to 
selectively activate bovine γδ TEM subsets in the peripheral and the mucosal compartment, may 
relate with protection or resistance to TB infection (10).  However, the implication of these γδ T 
cell changes in the bovine following M. bovis infection, cannot be fully appreciated, since the role 
of each γδ T effector/memory subset was not assessed.  Phenotypic analysis of human T cells has 
shown that memory CD27+ T cell subset have higher clonogenic potential and are able to secrete 
IL-2, IFNγ and TNFa.  This subset does not exhibit cytolytic activity without prior in vitro 
stimulation (11).  By comparison, CD27- γδ T cell subset can produce IFNγ and TNFα but do not 
secrete IL-2 and depend on IL-2 and IL-15 for proliferation (12).  Interestingly, CD27− cells 
contain perforin and granzyme and have high cytolytic activity without in vitro stimulation (11).  
Previous reports in the bovine, have shown that γδ T cells are capable of producing large amounts 
of Th1 cytokines, and inhibiting intracellular mycobacterial growth by producing perforin and 
granzyme (13).  Thus, further studies should identify the conditions for optimal activation of γδ 
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TEM subsets, and the functional role of each subset in vitro, using simultaneous staining with 
CD45R and CD27.    
Effector T cell function is dependent not only on the expression of cytokines but also on 
the capacity of these cells to migrate to sites of antigen encounter.  Examination of the lung-homing 
receptors, CXCR3 and CCR5, from circulating antigen-specific γδ T cell populations revealed that 
M. bovis infection resulted in upregulation of chemokine receptors when stimulated with antigen 
in vitro.  These results suggest that there might be a preferential migration of antigen-specific γδ 
T cells to the lung from peripheral blood after M. bovis infection, as seen in granuloma lesions.  
Surprisingly, BAL fluid recovered antigen-specific γδ T cells downregulated CXCR3 expression 
when stimulated with antigen in vitro.  Therefore, we cannot exclude the possibility that different 
populations of γδ T cells in the airways respond to infection.  Thus, detailed characterization of M. 
bovis-specific γδ T cells using an in vitro migration assay might provide insight into the mechanism 
involved in γδ T cell tissue trafficking and homing and might explain differences between 
circulating and mucosal γδ T cells chemokine expression seen here.  Understanding these changes 
may shed light into strategies to more efficiently engage the γδ T cell response and may provide 
insight into incorporating γδ T cell specific activation in future vaccine strategies may confer 
enhanced protection against TB (4, 8).  
 
There is increasing evidence that appropriate activation of innate immune system is 
essential for protection against TB (14).  Earlier reports have shown that BCG induces a long-term 
state of “trained immunity” in innate cells that confers increased non-specific protection (15, 16).  
Therefore, the second part of this work was to test if M. bovis BCG vaccination elicits memory-
like traits in bovine innate cells, as described in humans and mice [reviewed (17)].  We demonstrate 
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that M. bovis BCG infection induces a ‘trained’ phenotype in bovine cells, characterized by 
increased production of proinflammatory cytokines, IL-1b, TNFa and IL-6, in response to 
secondary TLR challenge.  We also demonstrate that this cellular hyperresponsiveness correlated 
with a metabolic shift towards glycolysis, previously implicated in innate immune memory (18).  
The possibility that BCG elicits strong boosting effects on innate immune responses can have 
important consequences for developing new TB vaccines that may act more efficiently if 
combining effects on adaptive and innate immunity.  However, very little has been done to address 
this in the field of TB immunology.  Further work is needed to define if part of the protection 
induced by BCG against TB is mediated by innate immune memory and to investigate the 
mechanisms responsible for these effects.  Since the work described here utilized a live bacterium 
as ‘priming’ antigen, there are several possible components that may have elicited the response.  
Analysis of the mycobacterial components capable of stimulating this response in innate cells may 
provide insight into the mechanisms involved in ‘training’ and thus, provide better strategies to 
engage the innate immune system in the early response to mycobacteria. 
In addition to the changes in innate immunity in peripheral blood seen here and reported 
by others (15), there may be differences in respiratory mucosal innate cells.  Interestingly, a distinct 
response was observed here after BCG priming of in BAL fluid cells.  We observed that aerosol 
BCG vaccination did not result in enhanced cytokine production following TLR stimulation in 
bovine AMs in vitro.  Suggesting that a tissue-specific immune response may occur in the lung in 
response to BCG infection.  However, this experiment was performed in only 7 vaccinated calves 
at one fixed time point after ex vivo stimulation. Given the strong variation in the outbred 
population, a larger number of animals is strongly warranted.  Furthermore, in infection models 
with M. tb and M. avium, an overall shift of glucose metabolism from oxidative phosphorylation 
5 
to fermentation (the Warburg effect) has been reported, and this was linked to pro-inflammatory 
cytokine production and bacterial survival.   
In recent work by Gleeson et al., they demonstrated a shift from oxidative phosphorylation 
to anaerobic glycolysis in primary human AMs infected with M. tb in vitro. Inhibition of this shift 
resulted in decreased levels of proinflammatory IL-1β and decreased, increased levels of anti-
inflammatory IL-10, and increased intracellular bacillary survival.  Although induction of 
glycolytic reprogramming by M. tb infection did not directly impact TNF-α production, IL-1β was 
shown to augment TNF-α signaling; thus, glycolysis may also affect this cytokine indirectly at 
later time points (19).  Thus, an effective vaccine against TB might need to induce metabolic 
changes in AM that could facilitate early enhanced clearance of the bacillus.  Additionally, drugs 
that manipulate host metabolism (i.e., metformin, meclizine) may be exploited as adjuvants for 
future therapeutic and vaccination strategies.  Further studies in cattle, are needed in order to 
identify the optimal methods to enhance immunometabolism and training immunity in the future 
that may be specifically relevant to develop protective vaccination strategies against TB.   
 It is of pivotal importance to look beyond assumptions that Th1 cells and their cytokine 
signature are cornerstone for protection against TB.  There is good evidence that effective control 
of M. bovis infection requires not only properly activated adaptive immune responses but may also 
benefit from nonconventional memory-like responses from populations such as ‘trained’ innate 
monocytes and differentiated γδ T cells.  Our results are promising but a much better understanding 
of the memory-like responses is urgently needed.  More investigation is needed to optimize 
strategies to prime/boost memory-like responses and may be gained from well-planned studies in 
the bovine model.   
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Supplementary Figure 1. PBMC gating strategy. PBMCs from control (n= 10) or BCG–
vaccinated animals (n= 18) were labeled with CellTrace, and 5 × 10 6 cells/ml were cultured for 6 
days in the presence or absence of PPD-b.  Cells were labeled with anti-bovine γδ TCR or CD4 
and analyzed by flow cytometry for CellTrace dilution.  Gating hierarchy (gating sequence as 
depicted by the arrows): Single cells (SSC-A vs SSC-H), lymphocytes (SSC-A vs FSC-A), γδ T 
cells or CD4 and CellTrace dilution. Representative contour plots of proliferative responses to in 






Supplementary Figure 2. PBMC and BAL cells gating strategy. Approximately ~8 weeks after 
aerosol vaccination, IFNγ expression was analyzed in circulating (A, PBMC) and in mucosal (B, 
BAL) compartment from control (n=7) or BCG–vaccinated animals (n= 7). 1 x 10 6 cells/well were 
stimulated in vitro with PPD-b (200 IU/ml) for 16 hours. Cells were then stained for intracellular 
IFNγ expression and analyzed by flow cytometry. Gating hierarchy (gating sequence as depicted 
by the arrows): Single cells (SSC-A vs SSC-H), lymphocytes (SSC-A vs FSC-A), γδ T cells and 




Supplementary Figure 3. PBMC and BAL cells gating strategy. Approximately ~8 weeks after 
aerosol vaccination, IFNγ expression was analyzed in circulating (A, PBMC) and in mucosal (B, 
BAL) compartment from control (n=7) or BCG–vaccinated animals (n= 7). 1 x 10 6 cells/well were 
stimulated in vitro with PPD-b (200 IU/ml) for 16 hours. Cells were then stained for intracellular 
IFNγ expression and analyzed by flow cytometry. Gating hierarchy (gating sequence as depicted 
by the arrows): Single cells (SSC-A vs SSC-H), lymphocytes (SSC-A vs FSC-A), CD4 T cells and 




Supplementary Figure 4. BAL cells gating strategy for expression of chemokine receptors on 
mucosal γδ and CD4 T cells. BAL cells were isolated from calves ~8 weeks after vaccination. 
Cells were stimulated with PPD-b in vitro for 16 hours. Cells were surface stained and then 
analyzed by flow cytometry to study CXCR3 and CCR5 expression on mucosal M. bovis-specific 
γδ and CD4 T cells. Gating hierarchy (gating sequence as depicted by the arrows): Lymphocytes 
(SSC-A vs FSC-A), γδ T cells or CD4 cells, IFNγ+ and IFNγneg cells and CXCR3 or CCR5 




Supplementary Figure 5. PBMC cells gating strategy for expression of chemokine receptors 
on mucosal γδ and CD4 T cells. PBMCs were isolated from calves ~8 weeks after vaccination. 
Cells were stained with CellTrace dye and incubated with PPD-b for 6 days. Cells were surface 
stained and then analyzed by flow cytometry to study CXCR3 and CCR5 expression on circulating 
M. bovis-specific γδ and CD4 T cells. Gating hierarchy (gating sequence as depicted by the 
arrows): Lymphocytes (SSC-A vs FSC-A), γδ T cells or CD4 cells, proliferating and non-
proliferating cells (CellTrace dilution) and CXCR3 or CCR5 expression as shown in histogram. 
Analysis was performed with Flowjo software. 
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Supplementary Figure 6. PBMC and BAL-recovered cells expression of chemokine receptors 
on mucosal γδ and CD4 T cells. Cells were isolated from calves ~8 weeks after vaccination. Cells 
were stimulated in vitro as indicated in Materials and Methods, surface stained and then analyzed 
by flow cytometry to study CXCR3 and CCR5 expression on γδ and CD4 T cells. Analysis was 
performed with Flowjo software. Not significant (ns) difference from antigen-responsive cells 
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